Common use of Defined Term Section Clause in Contracts

Defined Term Section. Action Section 5.11(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).

Appears in 2 contracts

Samples: Agreement and Plan of Merger (Ensco PLC), Agreement and Plan of Merger (Pride International Inc)

AutoNDA by SimpleDocs

Defined Term Section. Action Envoy First Paragraph Equity Holder Release Section 5.11(a2.2(a) ADS Depositary Escrow Agent Section 4.3 Affected Employees 1.6(b)(iv) Escrow Agreement Section 5.12(a1.6(a)(iii) Affiliate Escrowed Cash Section 3.27 Agreement Preamble Antitrust Laws 2.2(e) Escrowed Consideration Section 5.4(c2.2(e) Applicable Laws Escrowed EBS Master Units Section 3.5(a2.2(e) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Estimated Closing Date Balance Sheet Section 1.2 Code 2.3(a)(i) Estimated Net Working Capital Amount Section 2.1(c)(iii)(A2.3(a)(i) Company Preamble Company Acquisition Proposal Estimated Working Capital Adjustment Section 5.2(a2.3(a)(i) Company Adverse Recommendation Change Final Adjustment Amount Section 5.2(d)(i2.3(a)(iv) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Financial Statements Section 3.3 Company Federal Privacy and Security Regulations Section 3.20(a) Federal Transaction Regulations Section 3.20(a) Funds Flow Statement Section 1.6(a)(xv) HIPAA Section 3.20(a) Indemnification Agreements Section 2.2(a) Indemnified Managers/Officers Section 5.3(a) Indemnified Person Section 7.7(a) Indemnified Person Customer Section 7.12(a) Indemnifying Person Section 7.7(a) Independent Accountants Section 2.3(a)(iii) IP Licenses Section 3.15(c) Joint IP Third-Party Infringement Claim Section 7.4(f) Leased Real Property Section 3.5(d3.6(a) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Letter of Transmittal Section 2.2(a) Exchange Fund Listed Patents Section 7.2(d) Majority Holders Section 8.12(a) Xxxx Xxxx Employment Agreement Section 1.6(a)(vii) Material Customers Section 3.19(a) Material Suppliers Section 3.19(b) Member Release Section 2.2(a) Exchange Ratio Members’ Representative Section 2.1(c)(i8.12(a) Excluded Shares Members’ Representative Authorized Payments Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c2.2(d)(i) Merger Recitals Merger Consideration Section 2.1(c)(i2.2(b) Merger Sub Preamble New Financing Commitments First Paragraph Xxxxxx Xxxx Employment and Consulting Agreement Section 5.13(a1.6(a)(vii) Non-U.S. Antitrust Laws Delivering Company Members Section 5.4(a)(i2.2(f) NonOptions Section 2.6(a) Option Holders Section 2.6(a) Option Letter Agreements Section 2.6(a) Option Payment Section 2.6(b) Per Unit Merger Consideration Section 2.2(c) Post-U.S. Company Benefit Closing Infringement Section 7.4(f) Pre-Amendment Option Plan Section 3.11(a3.4(d) vi Pre-Amendment Plan Option Payments Section 2.6(a) Defined Term Section NonPre-U.S. Parent Benefit Amendment Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits 2.6(a) Pre-Closing Infringement Section 4.5(b7.4(f) Parent Permitted Liens Pre-Closing Tax Claim Section 4.21(a6.8 Pre-Closing Tax Period Section 7.2(c) Parent Real Property Purchase Price Allocation Section 4.5(d6.6 Reference Balance Sheet Date Section 3.3 Restrictive Covenant Agreements Section 1.6(a)(iv) Parent Representatives Second Look Collections Section 5.16(a2.3(c) Parent Reports Second Look Period Section 4.7(a2.3(c) Parent Shareholder Approval Straddle Period Section 4.20 Parent Superior Proposal 6.2 Subscription Agreement Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d1.6(a)(ii) Surviving Entity Section 1.1 tax(esTail Policy Section 5.3(b) TBOC Section 3.10(f) 1.1 Third Party Provision Claim Section 8.3 to the knowledge of 7.7(a) TLLCA Section 8.9(b) UK FSMA 1.1 Unaudited Financial Statements Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).3.3

Appears in 2 contracts

Samples: Equity Holder Release (Emdeon Inc.), Agreement and Plan of Merger (Emdeon Inc.)

Defined Term Section. Action First Surviving Company Section 5.11(a1.1(a) ADS Depositary FLSA Section 4.3 Affected Employees 2.16(a) GDPR Section 5.12(a2.8(a)(xiv) Affiliate Governmental Grant Section 3.27 Agreement Preamble Antitrust Laws 2.8(a)(vii) HIPAA Section 5.4(c2.8(a)(xiv) Applicable Laws ICT Infrastructure Section 3.5(a2.8(a)(ix) Assumed Option Inbound Licenses Section 2.1(c)(iii)(A2.8(j)(i) Assumed RSU Award Indemnification Agreements Section 2.1(c)(v)(B5.6(a) Book Entry Share Insurance Policies Section 2.1(c)(i2.18 Intellectual Property Rights Section 2.8(a)(x) Business Day Intended Tax Treatment Section 8.9(k5.8(a) Cash-Only Shares International Plan Section 2.1(c)(i2.15(k) Certificate of Merger Section 1.1 Class A Ordinary Shares Key Company Shareholders Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Key Parent Stockholders Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Leased Real Property Section 3.5(d2.7 Letter of Transmittal Section 1.10(b) Licensed Company Reports Intellectual Property Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c2.8(a)(xi) Merger Recitals Merger Consideration Filing Documents Section 2.1(c)(i1.3(b) Merger Sub I Preamble New Financing Commitments Merger Sub II Preamble Merger Subs Preamble Notice of Meeting Section 5.13(a5.1(b) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f2.12 Open Source Materials Section 2.8(a)(xii) Outbound Licenses Section 2.8(j)(i) Parent Preamble Parent ADS Author Section 3.6(e) Parent Board Recitals Parent Adverse Recommendation Change Capitalization Date Section 5.16(d)(i3.3(a) Parent Alternative Proposal Common Stock Consideration Cap Section 5.16(a1.5(b) Parent Benefit Plans Confidential Information Section 4.11(a3.6(f) Parent Disclosure Schedule Article 4 Financial Statements Section 3.4(c) Parent Material Adverse Effect Financial Statements Section 4.1 3.4(c) Parent Material Contract Section 4.23(a3.8(a) Parent Options Officers Certificate Section 4.3 8.4 Parent Permits Section 4.5(b3.9(b) Parent Permitted Liens Privacy Commitments Section 4.21(a3.6(l) Parent Real Property SEC Reports Section 4.5(d3.4(a) Parent Representatives SEC Reports Section 5.16(a3.4(a) Parent Reports Security Incident Section 4.7(a3.6(n) Parent Shareholder Approval Stockholders Meeting Section 4.20 Parent Superior Proposal Section 5.16(d)(ii5.3(a) Parent UK Prospectus Virtual Data Room Section 5.7(d)(i10.12(h) Per Share CashParent Voting Agreement Recitals PCI-Only Additional Cash Amount DSS Section 2.1(c)(i2.8(a)(xiv) Per Share Cash Amount Personal Data Section 2.1(c)(i2.8(a)(xiii) Per Share Stock Amount PIPEDA Section 2.1(c)(i2.8(a)(xiv) Person PIPL Section 3.5(e2.8(a)(xiv) PFIC PRC Section 4.10(b2.8(a)(xiv) Proxy Statement/Prospectus Pre-Closing Period Section 5.7(a4.1 Defined Term Section Preferred Consent Section 2.22 Parent Stockholder Proposals Section 1.5(d) Regulatory Filings Privacy Laws Section 3.6(b2.8(a)(xiv) Process Section 2.8(a)(xv) Processing Section 2.8(a)(xv) Prohibited Party Lists Section 2.12 Registrar of Companies Recitals Regulation D Recitals Required Jurisdiction Company Shareholder Vote Section 6.1(b)(iii2.22 Required Parent Stockholder Vote Section 3.11 Requisite Holders Section 2.22 RSP Withdrawal Section 5.14 SAFE Section 5.16 SAFE Circular No. 7 Section 5.16 Second Effective Time Section 1.3(b) Returns Second Merger Recitals Second Merger Filing Documents Section 3.10(a1.3(b) Rule 16b-3 Second Plan of Merger Section 5.9 Xxxxxxxx1.3(b) Second Surviving Company Section 1.1(b) Security Incident Section 2.8(q) Shrink-Xxxxx Act Wrap Software Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b2.8(a)(xvi) Significant Subsidiary Supplier Section 3.4 Subsidiary 2.20 SOX Section 8.9(d3.4(a) Surviving Entity Stock Consideration Section 1.1 tax(es1.5(a) Tail D&O Policy Section 3.10(f5.6(b) Third Party Provision Trade Laws Section 8.3 to the knowledge of 2.12 Trade Secrets Section 8.9(b2.8(a)(xix) Transfer Taxes Section 5.8(a) UK FSMA Section 2.2(b)(i2.8(a)(xiv) UK Prospectus Rules GDPR Section 5.7(d)(i2.8(a)(xiv) UKLA Unaudited Balance Sheet Section 5.7(d)(i2.4(a) U.S. Company Benefit Plan Unaudited Balance Sheet Date Section 3.11(a2.4(a) U.S. Parent Benefit Plan VCPDA Section 4.11(a2.8(a)(xiv) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”Virtual Data Room Section 10.12(h) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”Waived 280G Benefits Section 5.1(d) Warrant Consideration Section 1.5(a), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).

Appears in 1 contract

Samples: Agreement and Plan of Merger and Reorganization (Nuvation Bio Inc.)

Defined Term Section. Action Section ‎Section 5.11(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 ‎Section 3.22 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section ‎Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Phantom Unit Award Section 2.1(c)(v)(B‎Section 2.1(b)(iv)(B) Book Entry Share Section 2.1(c)(iUnit ‎Section 2.1(b)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i‎Section 8.9(y) Certificate of Merger Section ‎Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section ‎Section 1.2 Closing Date Section ‎Section 1.2 Code Section 2.1(c)(iii)(A) Recitals Company Preamble Company Acquisition Alternative Proposal Section 5.2(a‎Section 5.2(e)(i) Company Adverse Recommendation Change Section 5.2(d)(iAcquisition Agreement ‎Section 5.2(c) Company Benefit Plans Section 3.11(a‎Section 3.11 Company Board Recitals Company Board Recommendation ‎Section 5.3(b) Company Certificate Section 2.1(c)(i‎Section 2.1(b)(i) Company Change in Recommendation ‎Section 5.2(c) Company Common Stock Units Recitals Company Disclosure Schedule Article Letter ‎Article 3 Company ESPP Section 5.12(dIntervening Event ‎Section 5.2(e)(ii) Company Intervening Event Change in Recommendation ‎Section 5.2(d) Company LLC Agreement ‎Section 8.9(g) Company Material Adverse Effect Section ‎Section 3.1 Company Material Contract Section 3.23(a‎Section 3.20(a) Company Notice of Change in Recommendation ‎Section 5.2(c) Company Notice of Intervening Event Change in Recommendation ‎Section 5.2(d) Company Permits Section ‎Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 ‎Section 3.18 Company Real Property Section ‎Section 3.5(d) Company Reports Section ‎Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii‎Section 5.2(e)(iii) Defined Term Section Competition Action Section 5.4(c) Company Unitholder Approval ‎Section 3.17 Company Unitholder Meeting ‎Section 3.17 Confidentiality Agreement Section 5.2(a‎Section 8.9(o) Conflicts Committee Recitals Conflicts Committee Financial Advisor ‎Section 3.14 constructive knowledge ‎Section 8.9(c) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).‎Section 3.22

Appears in 1 contract

Samples: Agreement and Plan of Merger (Transocean Partners LLC)

Defined Term Section. Action Section 5.11(aAgreement Date Introduction Allowed Administrative Claim 1.10 Allowed Claims Preliminary Statement Allowed DIP Credit Facility Claim 1.10 Allowed Tax Claim 1.10 Amended Plan Preliminary Statement Approval 2.14(d) ADS Depositary Section 4.3 Affected Employees Section 5.12(aAssisted Living Facility 2.16(b) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(cAssisted Living Services Business 2.16(b) Applicable Laws Section 3.5(aAudited Debtor Financial Statements 2.5(a) Assumed Option Section 2.1(c)(iii)(ABankruptcy Code 2.1(a) Assumed RSU Award Section 2.1(c)(v)(BBankruptcy Court Preliminary Statement Bankruptcy-Related Requirements 4.5 Break-Up Fee 4.8 Business Entity 2.4(a) Book Entry Share Section 2.1(c)(iBuyer Introduction Buyer Disclosure Schedule Article III Buyer Expense Amount 4.8 Buyer HSR Reimbursement 2.8(b) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(iBuyer Material Adverse Effect Article III CERCLA 2.18(a) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Chapter 11 Proceeding Preliminary Statement Closing Section 1.2 Closing Working Capital 1.10(a) Code 2.8(b) Confirmation Order Preliminary Statement Contract 2.13(b) Debtor Introduction Debtor Acquisition Proposals 4.7 Debtor Affiliated Group 2.8(b) Debtor Affiliated Period 2.8(b) Debtor Authorizations 2.14(a) Debtor Balance Sheet Date Section 1.2 Code Section 2.1(c)(iii)(A2.5(a) Company Preamble Company Acquisition Proposal Section 5.2(aDebtor Business Entity 2.4(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Debtor Disclosure Schedule Article 3 Company ESPP Section 5.12(dII Debtor Employee Benefit Plans 2.17(a) Company Debtor Financial Statements 2.5(a) Debtor Group 2.8(b) Debtor Intellectual Property 2.11(a) Debtor Licenses and Authorizations 2.14(b) Debtor Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(aArticle II Debtor State Applications 2.14(b) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Debtor Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a1.5(b) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).-48

Appears in 1 contract

Samples: Agreement and Plan of Merger (Alterra Healthcare Corp)

Defined Term Section. Action Section 5.11(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 3.1 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A) 3.1 Company Preamble Company Acquisition EGM Section 6.5 Company EGM Proposals Section 6.5 Company SEC Documents Section 4.13(a) Company Subsidiaries Section 4.3 Convening Notice Section 3.3(b) Convening Notice Publication Section 6.5 Effective Date Preamble English Bribery Laws Section 4.22 Exchange Act Section 4.13(a) FCPA Section 4.22 First Aggregate Subscription Price Section 2 First Closing Section 3.1 First Closing Date Section 3.1 First Securities Section 2 Governmental Entity Section 4.5 Governmental Licenses Section 4.11 Healthcare Authorities Section 4.12 IFRS Section 4.13(b) Investor Preamble Investor Designee Proposal Section 5.2(a) Company Adverse Recommendation Change 6.5 Investor Designee Proposal Designees Section 5.2(d)(i) Company Benefit Plans 6.5 4 Defined Term Section 3.11(a) Company Certificate Investor Designee Proposal Notice Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP 6.5 IT Systems and Data Section 5.12(d) Company 4.28 Material Adverse Effect Section 4.1(b) Money Laundering Laws Section 4.24 OECD Convention Section 4.22 Ordinary Shares Other IP Agreements Recitals Section 4.27(c) Other Licenses Section 4.11 Permitted Encumbrances Section 4.27(d) Policies Section 4.29 Price Per Share Section 2 Privacy Laws Section 4.29 Rule 144 Section 5.8 Sanctions Section 4.23 SEC Section 4.7 Second Aggregate Subscription Price Section 2 Second Closing Section 3.1 Company Material Contract Second Closing Date Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior 3.1 Second Closing Proposal Section 5.2(d)(ii) Defined Term 6.5 Second Securities Section Competition Action 2 Securities Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) 2 Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”4.13(a), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).

Appears in 1 contract

Samples: Subscription Agreement (Fortress Investment Group LLC)

Defined Term Section. Action Additional Increment Section 5.11(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 2.1 Agreement Preamble Antitrust Alternate Transaction Agreement Section 8.1(d) Anti-Bribery Laws Section 5.4(c5.25 Approval Conditions Section 10.1(b)(iii) Applicable Laws Assigning Investor Section 3.5(a3.5(b) Assumed Option Auction Date Section 2.1(c)(iii)(A7.10(a)(vi) Assumed RSU Award Authorized Cleansing Party Section 2.1(c)(v)(B7.19(b) Book Entry Share Bankruptcy Code Recitals Bankruptcy Court Recitals Base DIP Conversion Amount Section 2.1(c)(i3.1(c)(i) Business Day Base Projected Cash Balance Section 8.9(k3.1(c)(i) Cash-Only Bidders Section 7.10(a)(i) Binding Proposal Section 7.10(a)(iii) Binding Proposal Bid Deadline Section 7.10(a)(iii) Chapter 11 Proceedings Recitals Cleansing Release Section 7.19(a) Commitment Premium Section 4.1 Commitment Premium Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A3.1(g) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a5.21(a) Company Certificate Compliance Criteria Section 2.1(c)(i7.24 Confirmed Plan Section 8.1(b) Company Common Stock Debtor Recitals Company Determination Date Section 3.3(b) DIP Conversion Section 3.2(a) Disclosure Schedule Letter Article 3 Company ESPP V Disclosure Statement Cleansing Release Section 5.12(d7.19(a) Company Material Adverse Effect Emergence MIP Vested Grant Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company 5.4 Employee Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a5.14(a) ERISA Section 3.11(a5.21(a) ERISA Affiliate Exit Financing Section 3.11(c) Equity Compensation Exchange Ratio 7.14 Exit Financing Documents Section 2.1(c)(i) Exchange Act 7.14 Exit Term Loan Section 3.4 Exchange Agent 7.14 Exit Revolving Facility Section 2.2(a) Exchange Fund 7.14 Expense Reimbursement Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e4.3(a) Fee Capped Months Section 7.5(b7.25 Filing Party Section 7.12(b) Final Parent Stock Price Cleansing Release Section 2.1(c)(i7.19(a) Financing Financial Reports Section 5.13(a7.8(a) Financing Commitments Financial Statements Section 5.13(a5.9(a) Financing Sources Foreign Plan Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a5.21(e) GAAP Section 3.7(b5.9(a) Governmental Entity Indemnified Claim Section 3.6(b9.2 Indemnified Person Section 9.2 Indemnifying Party Section 9.2 Independent Directors Section 7.16(a) Governmental Official Investor Preamble Joint Filing Party Section 3.5(e7.12(c) Hazardous Materials Legal Proceedings Section 3.13(b5.13 Losses Section 9.1(a) HSR Market Maker Section 7.13(d)(iii) Material Business Intellectual Property Section 5.15(b) Material Technology Section 5.15(b) Minimum Increment Section 2.1 MNPI Section 7.19(a) Money Laundering Laws Section 5.26 Multiemployer Plans Section 5.21(b) Notice of Results Section 3.3 OFAC Section 5.27 Outside Date Section 10.1(b)(iii) Party Preamble PATRIOT Act Section 3.6(b5.26 Permitted Claim Transferee Section 7.13(d)(i) Indemnified Party(iesPetition Date Recitals Plan Support Joinder Agreement Section 7.13(d)(i) Pre-Closing Period Section 5.11(a7.6(a) IRS Professional Fee Caps Section 3.11(a7.25 Projected Cash Balance Section 3.1(b) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Registered Intellectual Property Section 4.5(d5.15(a) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Required Combined Offering and Conversion Amount Section 2.1(c)(i3.1(a) Per Share Cash Amount Results Date Section 2.1(c)(i3.3(a) Per Share Stock Amount Right Section 2.1(c)(i) Person 2.1 Rights Offering Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).2.1

Appears in 1 contract

Samples: Backstop Conversion Commitment Agreement (Global Geophysical Services Inc)

Defined Term Section. Action Closing Consideration Spreadsheet Section 5.11(a6.9(b) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Date Section 1.2 Code 2.2 COBRA Section 2.1(c)(iii)(A3.23(e) Company Preamble Company Acquisition Proposal Confidential Information Section 5.2(a3.10(h) Company Adverse Recommendation Change Confidentiality Agreement Section 5.2(d)(i6.2 Disputed Items Section 2.13(d) Company Benefit Plans Dissenting Shares Section 3.11(a2.6(e) Company Certificate Effective Time Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract 2.2 ERISA Section 3.23(a) Company Permits ERISA Affiliate Section 3.5(b3.23(a) Company Permitted Liens Escrow Agent Section 3.21(a2.8 Estimated Working Capital Adjustment Section 2.13(b) Company Preferred Stock Final Working Capital Amount Section 3.3 Company Real 2.13(d) Fundamental Representations Section 8.2(a) Indemnified Person(s) Section 8.2(b)(i) Indemnifying Party Section 8.2(b)(i) Initial Termination Date Section 8.2(a) IP Representations Section 8.2(a) Issued Patents Section 1.1(a) JAMS Section 8.6(a) Merger Recital A Merger Sub Introductory Paragraph Offer Letter Section 6.5 Patent Applications Section 1.1(b) Patents Section 1.1(b) Pre-Closing Tax Period Section 9.2(b)(i) Property Taxes Section 6.12(e) Related Party Section 3.11 Release Date Section 8.3(b) Stockholders’ Agent Introductory Paragraph Solicitation Statement Section 3.5(d) Company Reports Straddle Period Section 3.7(a6.12(e) Company Representatives Surviving Corporation Section 5.2(a) Company Restricted 2.1 Target Introductory Paragraph Target Balance Sheet Date Section 3.6 Target Capital Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii2.6(b) Defined Term Section Competition Action Target Common Stock Recital B Target Current Facilities Section 5.4(c3.21 Target Employee Plans Section 3.23(a) Confidentiality Agreement Target Facilities Section 5.2(a3.21 Target Financial Statements Section 3.4(a) control Target Intellectual Property Section 3.27 Cutoff Date Section 8.9(e3.10(b) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Target Option Plan Section 3.11(a3.5(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Target Options Section 4.3 Parent Permits 2.6(c) Target Products Section 4.5(b3.10(b)(iii) Parent Permitted Liens Target Tail Policy Section 4.21(a6.14(b) Parent Real Property Target Service Section 4.5(d3.10(m) Parent Representatives Target Warrants Section 5.16(a2.6(d) Parent Reports Tax Matter Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f6.12(d) Third Party Provision Intellectual Property Section 8.3 to the knowledge of 3.10(c) Trademarks Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”1.1(d), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).

Appears in 1 contract

Samples: Agreement and Plan of Merger (PROS Holdings, Inc.)

Defined Term Section. Action Accounting Firm" Section 5.11(a1.9(b)(ii) ADS Depositary "Acquiror" Preamble "Acquiror Indemnified Parties" Section 4.3 Affected Employees Section 5.12(a8.2(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A) Company Preamble Company "Acquiror Party" ARTICLE IV "Acquisition Proposal Proposal" Section 5.2(a) Company Adverse Recommendation Change "Additional Blocker Contractual Rights" Section 5.2(d)(i5.14 "Affected Members" Section 9.2 "Agreement" Preamble "Allocation Disputed Amounts" Section5.10(j)(ii) Company Benefit Plans "Basket" Section 3.11(a8.6(b) "Blocker A" Preamble "Blockers" Preamble "Blocker Allocation" Section 5.10(j)(ii) "Blocker Certificates of Merger" Section 1.1(b) "Blocker Default" Section 5.14 "Blocker Letter of Transmittal" Section 1.4 "Blocker Merger Sub" Preamble "Blocker Merger Sub 1" Preamble "Blocker Merger Sub 2" Preamble "Blocker Merger Sub 3" Preamble "Blocker Merger Sub 4" Preamble "Blocker Written Consent" Section 1.12 "Claim" Section 8.5(a) "Claim Notice" Section 8.5(a) "Closing" Section 6.1 "Closing Certificate" Section 1.9(a) "Closing Date" Section 6.1 "Closing Statement" Section 1.9(a) "COBRA" Section 3.15(h) "Company" Preamble "Company Certificate of Merger" Section 2.1(c)(i1.2(b) "Company Common Stock Letter of Transmittal" Section 1.4 "Company Merger Sub" Preamble "Confidentiality Agreement" Section 5.13 "Consultant Proprietary Information Agreement" Section 3.7(j) "Contaminants" Section 3.7(d) "Contested Claim" Section 8.8(a)(ii) "Continuing Employee" Section 5.8 "Contributor" Section 3.7(j) "Covered Filing" Section 5.10(g) "CRAT" Section 5.15 "CRAT Equity Purchase" Section 5.15 "D&O Indemnified Party" Section 5.4(a) "D&O Tail Policy" Section 5.4(a) "Data Activities" Section 3.7(p) "Defaulting Blocker" Section 5.14 "Disclosure Schedules Section 5.5 "Disputed Amounts" Section 1.9(b)(ii) "Employee Proprietary Information Agreement" Section 3.7(j) "Employment Documents" Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval "Environmental Laws" Section 3.20 Company Stock Option "ERISA Affiliate" Section 2.1(c)(iii)(A3.15(h) Company Superior Proposal "Escrow Account" Section 5.2(d)(ii) Defined Term 1.10 "Escrow Agreement" Section Competition Action 1.10 "Escrow Amount" Section 5.4(c) Confidentiality Agreement 1.10 "Escrow Fund" Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).1.10

Appears in 1 contract

Samples: Agreement and Plan of Merger (Q2 Holdings, Inc.)

Defined Term Section. Action Section 5.11(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 ‎Section 2.02 Closing Date ‎Section 2.02 Code ‎Section 1.01 Commitment Letter Section 1.2 Code Section 2.1(c)(iii)(A5.15(b) Company Preamble Company Acquisition Proposal Section 5.2(a401(k) Plan ‎Section 5.07(f) Company Adverse Recommendation Change Section 5.2(d)(i‎Section 5.02(d) Company Benefit Plans Section 3.11(a) Balance Sheet ‎Section 1.01 Company Certificate Section 2.1(c)(iBalance Sheet Date ‎Section 1.01 Company Board Recommendation ‎Section 3.02(b) Company Common Stock Recitals ‎Section 1.01 Company Disclosure Schedule Article 3 Equity Awards ‎Section 2.07(d)(iv) Company Equity Plan ‎Section 1.01 Company ESPP Section 5.12(d‎Section 2.07(d)(iii) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Intellectual Property ‎Section 1.01 Company Preferred Stock Section 3.3 ‎Section 1.01 Company Real Registered Intellectual Property Section 3.5(d‎Section 3.16(a) Company Reports Section 3.7(aRSU ‎Section 2.07(d)(ii) Company Representatives Section 5.2(aRSU Payments ‎Section 2.07(d)(ii) Company Restricted Stock Awards Section 2.1(c)(ivSEC Documents ‎Section 3.06(a) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(vShareholder Approval ‎Section 3.02(a) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A‎Section 2.07(d)(i) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Termination Fee ‎Section 1.01 Confidentiality Agreement Section 5.2(a‎Section 5.04(c) control Section 3.27 Cutoff Date Section 8.9(eContinuing Employees ‎Section 5.07(a) Definitive Financing Agreements Section 5.13(bContract ‎Section 1.01 Credit Agreement ‎Section 1.01 Current Premium ‎Section 5.06(c) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(aD&O Insurance ‎Section 5.06(c) DGCL Recitals Disclosure Letter ‎Article 3 Dissenting Shares Section 2.1(c)(viiShare ‎Section 2.08(i) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 ‎Section 2.03 End Date ‎Section 7.01(b)(i) Environmental Laws Section 3.13(a) ‎Section 1.01 ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) ‎Section 1.01 Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) ‎Section 1.01 Excluded Shares Section 2.1(c)(ii‎Section 2.07(b) FCPA Section 3.5(e) Existing Credit Facility Terminations ‎Section 5.11 Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(iLetter ‎Section 4.07(a) Financing Section 5.13(a) Financing Commitments Section 5.13(a5.15(b) Financing Sources Section 5.13(a‎Section 4.07(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) FRAND Obligation ‎Section 1.01 GAAP Section 3.7(b) ‎Section 1.01 Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Authority ‎Section 1.01 Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).‎Section 1.01

Appears in 1 contract

Samples: Agreement and Plan of Merger (Keysight Technologies, Inc.)

Defined Term Section. Action Section 5.11(aAccounts Receivable 2.1(a)(ii) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Acknowledgement and Agreement 7.16 Acquisition Recitals Agreement Preamble Antitrust Laws Section 5.4(cAgreement Date Preamble Apportioned Obligations 7.17(c) Applicable Laws Section 3.5(aArticles of Dissolution 7.16 Assumed Benefit Plans 2.1(a)(xiv) Assumed Option Section 2.1(c)(iii)(ALiabilities 2.2(a) Assumed RSU Award Section 2.1(c)(v)(BPlans 4.3(b) Book Entry Share Section 2.1(c)(iBenefit Plan 4.17(a) Business Day Section 8.9(kBoard Approval 4.4(b) Cash-Only Shares Section 2.1(c)(iCap 10.3(a) Claim Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 10.5 Closing Section 1.2 3.1 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A) 3.1 Company Preamble Company Acquisition Proposal Advisors 7.2(a) ** ** Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2 Defined Term Section 5.2(aCompany Agreement Date Financial Statements 4.5(a) Company Adverse Recommendation Change Section 5.2(d)(iBalance Sheet 4.5(a) Company Benefit Plans Section 3.11(aBalance Sheet Date 4.5(c) Company Certificate Section 2.1(c)(iClosing Financial Statements 8.3(s) Company Common Stock Recitals Company Disclosure Schedule Article 3 IV Company ESPP Section 5.12(dExpense Shortfall 3.3(f) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(aFinancial Statements 4.5(a) Company Permits Section 3.5(bIndemnifiable Damages 10.2(b) Company Permitted Liens Section 3.21(aIndemnified Persons 10.2(b) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(dIndemnifying Person 10.2(a) Company Reports Section 3.7(aIP Contracts 4.14(c)(i) Company Representatives Section 5.2(aMarks 7.15 Company Permits 4.9(b) Company Restricted Stock Awards Section 2.1(c)(ivProducts 4.22 Company Registered IP 4.14(e) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(vTransaction Expenses 2.2(b)(vi) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(AVoting Debt 4.3(d) Company Superior Proposal Section 5.2(d)(iiConfidentiality Agreement 7.3(a) Consents 2.4 Contingent Payments 3.6 Corporate Records 2.1(b)(ii) Dispute Notice 3.3(b) Disputed Amounts 3.3(e) DOL 4.17(b) Earnout Dispute 3.2(c)(vi)(A) Earnout Dispute Term 3.2(c)(vi)(A) Earnout Term 3.2(c)(ix) EGEN-001 GBM Milestone 3.2(c)(ii) EGEN-001 GBM Payment 3.2(c)(ii) EGEN-001 GBM Product 3.2(c)(ii)(B) EGEN-001 Ovarian Cancer Milestone 3.2(c)(i) EGEN-001 Ovarian Cancer Payment 3.2(c)(i) EGEN-001 Ovarian Cancer Product 3.2(c)(i)(A) ERISA 4.17(a) ERISA Affiliate 4.17(d) Excluded Assets 2.1(b) Excluded Contracts 2.1(b)(v) Excluded Liabilities 2.2(b) Fraud 10.1 Hercules 5.2(b) Hercules Loan Agreement 5.2(b) Holdback Balance 10.4 ICC Rules 3.2(c)(vi)(B) Indemnifiable Damages 10.2(b) Indemnification Funds 10.2(a) ** ** Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2 Defined Term Section Competition Action Section 5.4(cIndemnified Persons 10.2(b) Confidentiality Agreement Section 5.2(aIndemnifying Persons 10.2(b) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(aIndependent Accounting Firm 3.3(c) IRS Section 3.11(a4.17(b) Liens Section 3.4 Material Adverse Effect Section 8.9(cLeased Real Property 4.12(a) Merger Recitals Merger Consideration Section 2.1(c)(iLeases 4.12(a) Merger Sub Preamble New Financing Commitments Section 5.13(aLock-Up Agreement 3.5(b) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(dNew Litigation Claim 7.7 Nonassignable Assets 2.4 Objection Notice 3.2(c)(vi)(A) Parent Representatives Section 5.16(aOffer Letter Recitals Parachute Payment Waiver 7.11 Post-Closing Apportioned Period 7.17(c) Parent Reports Section 4.7(aPre-Closing Apportioned Period 7.17(c) Parent Shareholder Prohibited Transaction 4.33 Proxy Statement 7.1(a) Purchase Price 3.2 Purchaser Preamble Purchaser FDA Representative 6.3 Purchaser Financial Statements 5.3 Purchaser Indemnifiable Damages 10.2(a) Purchaser Indemnified Persons 10.2(a) Purchaser Indemnifying Person 10.2(b) Purchaser SEC Documents 5.3 Registration Rights Agreement 7.14 Representation Termination Date 10.1 Resale Registration Statement 7.14 Share Limit 3.4 Stockholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii7.1(b) Parent UK Prospectus Section 5.7(d)(isuccessful treatment 3.2(c)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(ior 3.2(c)(ii) Per Share Cash Amount Section 2.1(c)(iTermination Date 9.1(b) Per Share Stock Amount Section 2.1(c)(iTheraSilence Development Milestone 3.2(c)(iii)(B) Person Section 3.5(eTheraSilence Development Payment 3.2(c)(iii)(B) PFIC Section 4.10(bTheraSilence Development Products 3.2(c)(iii)(B) Proxy Statement/Prospectus Section 5.7(aTheraSilence License 3.2(c)(iii)(A) Regulatory Filings Section 3.6(bTheraSilence License Milestone 3.2(c)(iii)(A) Required Jurisdiction Section 6.1(b)(iiiTheraSilence License Payment 3.2(c)(iii)(A) Returns Section 3.10(aTheraSilence License Products 3.2(c)(iii)(A) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(aTrading Affiliates 4.33 Transferred Assets 2.1(a) SEC Section 3.7(aTransferred Contracts 2.1(a)(vi) Transferred Employee Liabilities 2.2(a)(ii) Voting Agreement Recitals ** ** Text Omitted and Filed Separately with the Securities Act Section 3.6(band Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).240.24b-2

Appears in 1 contract

Samples: Asset Purchase Agreement (Celsion CORP)

Defined Term Section. Action Section 5.11(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class Company Series A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d2.1(a) Company Reports Stock Option Plans Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) 2.4 Company Stockholder Approval Section 3.20 4.20 Company Stock Option Stockholder Written Consents Section 2.1(c)(iii)(A6.4(b) Company Superior Proposal Stockholders Preamble Company Termination Fee Section 5.2(d)(ii8.2(c) Defined Term Company Unaudited Financial Statements Section Competition Action Section 5.4(c4.7(b) Confidentiality Agreement Section 5.2(a6.5 Continuing Employees Section 6.11(c) control D&O Insurance Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b6.12 (b) Delaware Sub Preamble Deposit Agreement Law Recitals Drug Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals 4.17 Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 1.2 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio FDA Section 2.1(c)(i) Excluded Shares 3.6 FDCA Section 2.1(c)(ii) FCPA 3.6 Investors Section 3.5(e) Fee 6.20 Medical Device Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) 4.17 Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Multiemployer Plan Section 3.11(a3.10(c) vi Note and Security Disposition Section 6.20 Outside Date Section 8.1(b) 72 Defined Term Section Non-U.S. Parent Preamble Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f3.10(a) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Board Section 5.16(d)(i3.4(b) Parent Alternative Proposal Board Approval Section 5.16(a3.4(b) Parent Benefit Plans By-Laws Section 4.11(a3.2 Parent Certificate Section 3.2 Parent Common Stock Section 2.1(a) Parent Deferred Compensation Plan Section 3.10(g) Parent Disclosure Schedule Article 4 III Parent Material Adverse Effect Expense Fee Section 4.1 8.2(c) Parent Financial Advisor Section 3.20 Parent Form 10-K Section 3.2 Parent Material Contract Section 4.23(a) 3.13 Parent Material Intellectual Property Section 3.16 Parent Name Change Section 6.21 Parent Options Section 4.3 3.3(a) Parent Permits Section 4.5(b3.6 Parent Preferred Stock Section 3.3(a) Parent Permitted Liens Recommendation Section 4.21(a6.4(a) Parent Real Property SEC Filings Section 4.5(d3.7(a) Parent Specified Compounds Section 3.17(b) Parent Stockholder Approval Section 3.21 Parent Stockholders’ Meeting Section 6.4(a) Parent Stock Rights Section 3.3(b) Defined Term Section Parent Termination Fee Section 8.2(b) Parent Voting Agreement Recitals Parent Warrants Section 3.3(a) Proxy Statement Section 3.5(b) Representatives Section 5.16(a) Parent Reports 6.5 Reverse Stock Split Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 6.10 Xxxxxxxx-Xxxxx Act Section 3.7(a3.7(d) SEC Section 3.7(a16 Section 6.11(a) Securities Act Purchase Agreement Section 3.6(b) Significant Subsidiary 6.20 Surviving Corporation Recitals Transfer Taxes Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).6.17

Appears in 1 contract

Samples: Agreement and Plan of Merger (Anesiva, Inc.)

Defined Term Section. Action Apple Eight Termination Fee Section 5.11(a8.3(c) ADS Depositary Apple Eight Unit Consideration Section 4.3 Affected Employees 2.1(a)(ii) Apple Eight Unit Ratio Section 5.12(a2.1(a)(ii) Affiliate Apple Eight Units Section 3.27 Agreement Preamble Antitrust Laws 2.1(a)(ii) Apple Nine Heading Apple Nine Advisors Section 5.4(c6.1(g) Applicable Laws Apple Nine Amendments Section 3.5(a1.6(b) Assumed Option Apple Nine Articles Section 2.1(c)(iii)(A1.6(a) Assumed RSU Award Apple Nine Articles Amendments Section 2.1(c)(v)(B1.6(b) Book Entry Share Apple Nine Bylaws Section 2.1(c)(i1.6(c) Business Day Apple Nine Bylaws Amendment Section 8.9(k1.6(c) Cash-Only Apple Nine Common Shares Recitals Apple Nine Dissenting Shares Section 2.1(c)(i2.3(b) Certificate Apple Nine Franchise Agreements Section 3.2(n)(ii) Apple Nine Management Agreement Documents Section 3.2(n)(iii) Apple Nine Material Contracts Section 3.2(l)(i)(P) Apple Nine Organizational Documents Section 3.2(r)(ii) Apple Nine Owned Hotels Section 3.2(n)(i) Apple Nine Prior Contamination Section 3.2(m)(iv) Apple Nine Properties Section 3.2(n)(i) Apple Nine SEC Documents Section 3.2(e)(i) Apple Nine Series A Shares Section 2.1(d) Apple Nine Series B Shares Recitals Apple Nine Shares Section 3.2(c)(i) Apple Nine Stock Options Section 3.2(c)(i) Apple Nine Termination Fee Section 8.3(e) Apple Nine Units Section 2.1(d) Apple REIT Heading Apple REITs Heading Apple Seven Heading Apple Seven Common Shares Section 2.1(a)(i) Apple Seven Consideration Section 2.1(a)(i) Apple Seven Merger Recitals Apple Seven Plan of Merger Section 1.1 Class 1.1(a) Apple Seven Series A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 2.1(a)(i) Apple Seven Series B Consideration Section 2.1(a)(i) Apple Seven Series B Shares Section 2.1(a)(i) Apple Seven Stock Option Section 2.1(e)(i) Apple Seven Termination Fee Section 8.3(b) Apple Seven Unit Consideration Section 2.1(a)(i) Apple Seven Unit Ratio Section 2.1(a)(i) Apple Seven Units Section 2.1(a)(i) Apple Ten Recitals Apple Ten Advisors Section 6.1(e) Articles of Merger Section 1.3 Defined Term Section Assignment and Transfer Agreement Section 6.1(j) Closing Section 1.2 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A) Recitals Companies Heading Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Heading Competing Transaction Section 3.25(a5.4(a) DGCL Conversion Agreements Recitals Dissenting Shares Section 2.1(c)(vii2.3(b) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).1.3

Appears in 1 contract

Samples: Agreement and Plan of Merger (Apple REIT Seven, Inc.)

Defined Term Section. Action Section 5.11(aCut-Off Date 5.5(b)(i) ADS Depositary Section 4.3 Affected Employees Section 5.12(aDamages 6.2(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only D&O Insurance 5.6 DGCL 1.1 Dissenting Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company 8.14 Effective Time 1.3 Employee Benefit Plans Section 3.11(a3.14(a) Company Certificate Section 2.1(c)(iEnvironmental Laws 3.12(a) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(dERISA 3.14(a) Company ERISA Affiliate 3.14(a) Exchange Act 3.4(b) Excluded Party 5.5(b)(i) Financial Advisor 3.20 Financial Statements 3.5(c) Foreign Benefit Plan 3.14(l) GAAP 3.5(b) Go-Shop Period 5.5(b)(i) Go-Shop Superior Proposal 5.5(b)(ii) Governmental Entity 3.4(b) Hazardous Substance 8.14 Indemnified Parties 5.6 Intellectual Property Rights 8.14 IP License Agreement 8.13 Law 3.4(a) Leased Real Property 3.17(c) Liens 3.2 Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) 8.14 Merger Recitals Merger Consideration Section 2.1(c)(i1.8(a) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi ii Defined Term Section Non-U.S. Parent Benefit Multiemployer Plan Section 4.11(a3.14(b) NYSE Necessary Consents 3.4(b) Newco Recitals OFAC Section 3.5(fOrder 3.4(a) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Owned Real Property Section 4.5(d3.17(b) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(iPaying Agent 2.1 PBGC 3.14(c) Person Section 3.5(e8.14 Properties 3.12(b) PFIC Section 4.10(bPromissory Note 8.14 Proxy Statement 5.2(a) Proxy Statement/Prospectus Section 5.7(aPurchaser Preamble Purchaser Ancillary Instruments 4.2 Purchaser’s Costs 8.14 Purchaser’s Renegotiation Right 5.5(a)(ii) Real Property Lease 3.17(c) Recent Balance Sheet 3.11(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(aLaw 8.14 Representatives 5.5(a) SEC Section 3.7(a3.5(a) Securities Act Section 3.6(b3.5(a) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(dSubsidiaries 8.14 Superior Proposal 8.14 Surviving Corporation 1.1 Taxes 8.14 Tax Return 8.14 Termination Date 7.1(b) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) Termination Fee 8.14 Transaction Expenses 8.14 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this "Agreement") dated is made and effective as of February 6October 10, 20112012, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride InternationalMEGTEC Systems, Inc., a Delaware corporation (the “Company”"Purchaser"), ENSCO Ventures LLCMTS WSP, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International IncorporatedInc., a Delaware corporation and an indirecta direct, wholly-owned subsidiary of Parent Purchaser ("Newco"), and TurboSonic Technologies, Inc., a Delaware Sub”corporation ("Company").

Appears in 1 contract

Samples: Agreement and Plan of Merger (Turbosonic Technologies Inc)

Defined Term Section. Action Section 5.11(aAgreed Claims §7.3(c) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(cBase Price 2.3(a) Applicable Laws Section 3.5(aXxxxx Preamble Business Recitals Certificate §7.3(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 §2.4 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A§2.4 Closing Date Financial Report §2.6(a) Company Closing Payment §2.3(a) Effective Time §2.4 Escrow Account §2.3(c) Escrow Agent §2.3(c) Escrow Agreement §2.3(c) Escrow Amount §2.3(c) Financial Statements §3.6(c) Hong Kong Purchase Agreement §5.12 Indemnification Cap §7.2(b)(i) Indemnification Claim §7.1(d) Indemnified Party §7.3(a) Indemnifying Party §7.3(a) Insurance Policies §3.13 Leases §3.9 Missed Contract §2.5(d) Noncompetition Agreements §2.5(a)(vii) Non-Transferable Assets §2.5(c) Party(ies) Preamble Company Acquisition Proposal Section 5.2(aPDT Preamble PDT Balance Sheet §3.6(b) Company Adverse Recommendation Change Section 5.2(d)(iPDT Covered Business Recitals PDT Interim Financial Statements §3.6(b) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(iiPDT UK Preamble PDT Ukraine Preamble Pre-Closing Tax Period §7.7(a) Defined Term Section Competition Action Section 5.4(cPurchase Price §2.3(a) Confidentiality Purchaser Preamble Purchaser Employment Date §5.9(a) Purchaser’s License Agreement Section 5.2(a§6.1(l) control Section 3.27 Cutoff Date Section 8.9(ePurchaser Losses §7.2(a) Definitive Financing Agreements Section 5.13(bRepurchase Notice §5.6 Schedules §1.4 Sellers Preamble Sellers’ License Agreement §6.2(k) Delaware Sub Seller Losses §7.2(c) Standard Exceptions §3.2 Subject Company Employee Plans §3.19(a) Tax Allocation §2.3(b) Tax Proceeding §7.7(c) Telefonix Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(aTelefonix Balance Sheet §3.6(a) DGCL Telefonix Business Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(fTelefonix Interim Financial Statements §3.6(a) Third Party Provision Section 8.3 to the knowledge of Section 8.9(bClaim §7.4(a) UK FSMA Section 2.2(b)(iThreshold §7.2(b)(ii) UK Prospectus Rules Section 5.7(d)(iTransaction Tax Deduction §7.7(b) UKLA Section 5.7(d)(iTransition Services Agreement §2.5(a)(xiii) U.S. Company Benefit Plan Section 3.11(aTransferred Employee §5.9(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).Uncollectible Accounts §5.6 Ukraine Purchase Agreement §5.13

Appears in 1 contract

Samples: Asset Purchase Agreement (Astronics Corp)

Defined Term Section. Action Holdback Amount Section 5.11(a1.05(a)(i)(C) ADS Depositary Indemnification Cap Section 4.3 Affected Employees 8.08(a) Indemnification Notice Section 5.12(a8.03 Indemnifying Party Section 8.03 Independent Auditor Section 1.06(c) Affiliate Intellectual Property Assets Section 3.27 Agreement 4.19(b) Interim Balance Sheet Section 4.08 Xxxxx Canada Preamble Antitrust Laws Leased Real Property Section 5.4(c4.12(a) Applicable Laws Licenses Section 3.5(a4.19(a) Assumed Option Licensed Excluded IP Section 2.1(c)(iii)(A4.19(h) Assumed RSU Award Litigation Notice Section 2.1(c)(v)(B8.03 Material Contracts Section 4.27 Onset Preamble Parent Preamble Policy or Policies Section 4.26(a) Book Entry Share Preliminary Allocation Section 2.1(c)(i1.07 Proprietary Intellectual Property Section 4.19(a) Purchaser Preamble Purchase Price Section 1.05(a) Purchaser Indemnified Parties Section 8.01 Purchaser Group Section 6.03 Purchaser’s Final Net Portfolio Value Determination Section 1.06(a) Qualifying Indemnity Loss Section 8.08(a)(i) Restricted Business Day Section 8.9(k10.03(a) Cash-Only Shares Restricted Contract Section 2.1(c)(i1.08 Restricted Period Section 10.02(a) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Second Closing Section 1.2 2.01 Second Closing Assets Section 1.01(b) Second Closing Date Section 1.2 Code 2.01 Second Closing Transfer Taxes Section 2.1(c)(iii)(A11.02 87 Defined term Section Second Interim Period Covenants Section 6.02 Securitized Assets Section 2.02(a)(i)(B)(I) Company Seller Preamble Company Acquisition Proposal Seller Indemnified Parties Section 5.2(a) Company Adverse Recommendation Change 8.02 Seller Material Consents Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f2.02(b)(ii) Third Party Provision Person Claim Section 8.3 to the knowledge of 8.03 Transition Committee Section 8.9(b) UK FSMA 11.05 Undisclosed Liabilities Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).4.28

Appears in 1 contract

Samples: Asset Purchase Agreement (Irwin Financial Corp)

Defined Term Section. Action Section 5.11(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Date Section 1.2 1.6 Code Section 2.1(c)(iii)(A1.9(a) Company Preamble Company Acquisition Proposal Competing Product Section 5.2(a7.1(a) Company Adverse Recommendation Change Competing Transaction Section 5.2(d)(i4.9 Confidential Information Section 4.10 DGCL Section 4.10(a) Company Domains Section 1.1(d) Escrow Section 1.5 Escrow Account Section 1.5 Escrow Agent Section 1.5 Escrow Agreement Section 1.5 Escrowed Consideration Section 1.5 Employee Benefit Plans Plan Section 3.11(a2.14(a) Company Certificate Environmental Law Section 2.1(c)(i2.19(b) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP ERISA Section 5.12(d2.14(a) Company Excluded Assets Section 2.3(a) Excluded Liabilities Section 1.4 Financial Statements Section 2.7(a) GAAP Section 2.7(a) Governmental Body Section 2.6 Hardware Section 1.1(f) Hazardous Substance Section 2.19(c) Indemnified Party Section 6.4 Indemnifying Party Section 6.4 Key Employees Section 1.7(g) Latest Balance Sheet Section 2.7(b) Latest Balance Sheet Date Section 2.7(a) Laws Section 2.11 Leased Real Property Section 2.18 Liabilities Section 1.4 Liens Section 2.3(b) Losses Section 6.2 Material Adverse Effect Section 3.1 Company Material Contract 2.1 Minimum Collectible Receivables Section 3.23(a6.2 Non-Competition Period Section 7.1(a) Company Permits Section 3.5(b2.12 Person Section 2.10 Prevailing Party Section 8.3 Purchase Price Section 1.5 Receivables Shortfall Section 6.2 Related Party Section 2.20 Releases Section 5.1(a) Company Permitted Liens Required Stockholder Vote Section 3.21(a) Company Preferred Stock 2.2 Retained Liabilities Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) 4.12 Seller Preamble Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Seller Board Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy StatementSeller Components Section 2.17(d) Seller Documents Section 2.2 Seller Employee Obligations Section 4.14 Seller Parties Section 6.3 Seller Proprietary Rights Section 2.17(a) Seller Software Section 2.17(j) Seller Stockholder Meeting Section 4.10(a) Services Section 2.17(a) Software Section 1.1(c) Tax/Prospectus Taxes Section 5.7(a2.9(b) Regulatory Filings Territory Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f7.1(a) Third Party Provision Licenses Section 8.3 to the knowledge of 2.17(b) Third Party Technology Section 8.9(b2.17(b) UK FSMA Transfer Taxes Section 2.2(b)(i2.19(a) UK Prospectus Rules WARN Act Section 5.7(d)(i4.14(c) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN [THE REMAINDER OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).PAGE INTENTIONALLY LEFT BLANK]

Appears in 1 contract

Samples: Asset Purchase Agreement (Intervoice Inc)

AutoNDA by SimpleDocs

Defined Term Section. Action Section 5.11(aExchange Fund 2.1 Exchange Ratio 1.4(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(aExcluded Party 8.3(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(cFDIA 4.28 FDIC 3.4 Form of Election 1.4(b)(ii) Applicable Laws Section 3.5(aForm S-4 3.4 FRB 3.5 GAAP 3.6 Governmental Entity 3.4 HSR Act 3.4 Indemnified Parties 6.7(a) Assumed Option Section 2.1(c)(iii)(AIndex Availability Date 8.1(i) Assumed RSU Award Section 2.1(c)(v)(BIndex Value 8.1(i) Book Entry Share Section 2.1(c)(iIntellectual Property 4.20(a) Business Day Section 8.9(kIRS 3.11(b) Cash-Only Shares Section 2.1(c)(iKnowledge 9.5 Leased Real Property 4.16(a) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Leases 4.16(a) Liens 3.2(c) Loans 4.23(a) Mailing Date Section 1.2 Code Section 2.1(c)(iii)(A1.4(b)(iii) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c3.1(a) Merger Recitals Merger Consideration Section 2.1(c)(i1.4(a) Merger Sub Preamble New Financing Commitments Section 5.13(aNASDAQ 2.2(e) Non-U.S. Antitrust Laws Section 5.4(a)(iNotice of Superior Proposal 8.3(a) Non-U.S. Company Benefit Plan Section 3.11(aOCC 3.5 OREO 4.23(b) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(fOther Regulatory Approvals 3.4 Owned Real Property 4.16(a) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) First Paragraph Parent Benefit Plans Section 4.11(a3.11(a) Parent Capital Stock 3.2(a) Parent Common Stock 1.4(a) Parent Disclosure Schedule Article 4 III Parent Material Adverse Effect Section 4.1 Data 3.19 Parent Material Contract Section 4.23(aERISA Affiliate 3.11(b) Parent Options Section 4.3 Incentive Plans 6.6(a) Parent-Owned Software 3.19 Parent Permits Section 4.5(bPreferred Stock 3.2(a) Parent Regulatory Agreement 3.14 Parent Reports 3.12 Defined Term Section Parent Stock Option 3.2(a) Parent Stock Plans 3.2(a) Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i4.16(c) Person Section 3.5(e9.5 Portfolio Loan 4.25(a) PFIC Section 4.10(bPremium Cap 6.7(b) Protected Period 6.6(b) Proxy Statement/Prospectus Section 5.7(a3.4 Public Proposal 8.3(a)(ii) Real Estate 4.16(a) Real Estate Liens 4.16(a) Regulatory Filings Section 3.6(bAgencies 3.5 Representative 1.4(b)(ii) Required Jurisdiction Section 6.1(b)(iiiRequisite Regulatory Approvals 7.1(a) Returns Section 3.10(aRequisite Shareholder Approval 7.1(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SBLF Redemption 1.8 SEC Section 3.7(a) 3.4 Securities Act Section 3.6(b3.4 Seller and Servicing Guides 4.25(a) Significant Serviced Loan 4.25(a) Servicing 4.25(a) Servicing Agreements 4.25(a) Software 4.20(a) State Agency 4.25(a) Starting Date 8.1(i) State Regulator 3.5 Stock Consideration 1.4(a) Stock Election 1.4(b)(ii) Stock Election Number 1.4(b)(i) Stock Election Shares 1.4(b)(v) Subsidiary Section 3.4 Subsidiary Section 8.9(d3.1(c) Superior Proposal 6.10(g) Surviving Entity Corporation Recitals Target First Paragraph Target Balance Sheet 4.6 Target Balance Sheet Date 4.6 Target Benefit Plans 4.12(a) Target Capital Stock 4.2(a) Target Charter 4.1(b) Target Common Stock 1.4(a) Target Data 4.20(b) Target Disclosure Schedule Article IV Target Dissenting Shares 1.4(e) Aa-3 Defined Term Section 1.1 tax(esTarget Employees 6.6(a) Section 3.10(fTarget ERISA Affiliate 4.12(a) Third Party Provision Section 8.3 to the knowledge of Section 8.9(bTarget Financial Statements 4.6 Target Intellectual Property 4.20(a) UK FSMA Section 2.2(b)(iTarget Loan 4.23(c) UK Prospectus Rules Section 5.7(d)(iTarget Material Contract 4.14(a) UKLA Section 5.7(d)(iTarget Preferred Stock 4.2(a) U.S. Company Benefit Plan Section 3.11(aTarget Regulatory Agreement 4.15 Target Representative 6.10(a) U.S. Parent Benefit Plan Section 4.11(aTarget Series C Preferred Stock 1.8 Target Series D Preferred Stock 4.2(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”Target Shareholder Approval 6.3(a) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”Target Shareholders’ Meeting 6.3(a) Target-Owned Software 4.20(b) Target Stock Options 1.7(a) Target Stock Plans 1.7(a) Target Subsidiaries 4.1(c) Tax 3.10(b) Taxes 3.10(b) TBCA 1.1(a) TDFI 3.4 Tennessee Secretary 1.2 Termination Fee 8.3(a) Trust Account Shares 1.4(a) Voting Agreements Recitals Voting Debt 3.2(b) Window Shop End Date 8.3(a), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).

Appears in 1 contract

Samples: Agreement and Plan of Merger (Pinnacle Financial Partners Inc)

Defined Term Section. Action Section 5.11(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Available Nalco Stock Plan Shares Section 2.1(c)(i2.10(e) Cash Consideration Section 2.7(a)(i) Cash Election Shares Section 2.7(a)(i) Certificate Section 2.7(f) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 2.3 Closing Section 1.2 2.2 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights 2.2 Confidentiality Agreement Section 2.5 Company RSU Awards 7.3(d) Continuing Employee Section 2.1(c)(v7.7(b) Company Stockholder Approval Converted Stock-Based Award Section 3.20 Company 2.10(b) Converted Stock Option Section 2.1(c)(iii)(A2.10(a) Company Superior Proposal D & O Insurance Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a7.9(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii2.7(c) Dissenting GAAP Section 4.7(b) Ecolab Preamble Ecolab Change in Recommendation Section 7.2(b) Ecolab Contracts Section 5.17(b) Ecolab Disclosure Letter Article V Ecolab Financial Advisor Section 5.22 Ecolab Permits Section 5.11(a) Ecolab Recommendation Section 7.2(b) Ecolab’s Counsel Section 7.19 Ecolab SEC Documents Section 5.6(a) Ecolab Share Issuance Section 5.4(b) Ecolab Stockholder Approval Section 2.1(c)(vii5.4(d) DLLCA Recitals Ecolab Stockholders Meeting Section 7.2(b) Ecolab Stock Plans Section 5.3(b) Ecolab Subsidiaries Section 5.2(a) Ecolab Subsidiary Section 5.2(a) Ecolab Termination Fee Section 9.3(b) Effective Time Section 1.1 Environmental Laws 2.3 Elected Cash Consideration Section 3.13(a2.8(a) ERISA Election Deadline Section 3.11(a2.9(b) ERISA Affiliate Election Form Section 3.11(c2.9(a) Equity Compensation Exchange Ratio Election Form Record Date Section 2.1(c)(i2.9(a) Exchange Act Election Period Section 3.4 2.9(b) End Date Section 9.1(b)(i) Exchange Agent Section 2.2(a3.1(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i3.1(b) Excluded Shares Section 2.1(c)(ii2.7(b) FCPA Foreign Ecolab Benefit Plan Section 3.5(e5.14(g) Fee Foreign Nalco Benefit Plan Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a4.15(g) Form S-4 Section 5.7(a) GAAP 4.9 FTC Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b7.4(b) Indemnified Party(iesPersons Section 7.9(a) Joint Proxy Statement/Prospectus Section 5.11(a7.1(a) IRS Mailing Date Section 3.11(a2.9(a) Liens Maximum Annual Premium Section 3.4 Material Adverse Effect Section 8.9(c7.9(a) Merger Recitals Merger Consideration Section 2.1(c)(i2.7(a) Merger Sub Preamble New Financing Commitments Nalco Preamble Nalco Change in Recommendation Section 5.13(a7.2(a) Non-U.S. Antitrust Laws Nalco Contracts Section 5.4(a)(i4.18(b) Non-U.S. Company Benefit Plan Nalco Disclosure Letter Article IV Nalco Financial Advisor Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent 4.22 Nalco Permits Section 4.5(b4.12(a) Parent Permitted Liens Nalco Recommendation Section 4.21(a7.2(a) Parent Real Property Nalco’s Counsel Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports 7.19 Nalco SEC Documents Section 4.7(a) Parent Shareholder Nalco Stock-Based Award Section 2.10(b) Nalco Stockholder Approval Section 4.20 Parent Superior Proposal 4.4(c) Nalco Stockholders Meeting Section 5.16(d)(ii7.2(a) Parent UK Prospectus Nalco Stock Option Section 5.7(d)(i2.10(a) Per Nalco Stock Plan Section 2.10(a) Nalco Subsidiaries Section 4.2(a) Nalco Subsidiary Section 4.2(a) Nalco Termination Fee Section 9.3(a) No Election Share Cash-Only Additional Cash Amount Section 2.1(c)(i2.7(a)(iii) Per Share Cash Amount No Election Value Section 2.1(c)(i2.8(b)(ii) Per Share Stock Amount Parties Preamble Party Preamble Representatives Section 2.1(c)(i7.3(a) Person Restraints Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a8.1(d) SEC Article IV Shortfall Number Section 3.7(a2.8(b) Securities Act Specified Nalco Contract Section 3.6(b6.1(q) Significant Subsidiary Stock Consideration Section 3.4 Subsidiary 2.7(a)(ii) Stock Election Shares Section 8.9(d2.7(a)(iii) Surviving Entity Corporation Section 1.1 tax(es) 2.1 Surviving Corporation Plans Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”7.7(b), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).

Appears in 1 contract

Samples: Agreement and Plan of Merger (Nalco Holding CO)

Defined Term Section. Action Conveyancing and Assumption Instruments Section 5.11(a1.1(27) ADS Depositary CPR Section 4.3 Affected Employees 8.2 Dispute Notice Section 5.12(a8.1 Disclosure Documents Section 1.1(28) Affiliate Distribution Preamble Distribution Agent Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c1.1(29) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Distribution Date Section 1.2 Code Section 2.1(c)(iii)(A1.1(30) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 1.1(31) Employee Matters Agreement Section 1.1(32) Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b1.1(33) Final Parent Stock Price Determination Section 2.1(c)(i1.1(34) Financing Section 5.13(a1.1(35) Financing Commitments Force Majeure Section 5.13(a) Financing Sources Section 5.13(a1.1(36) Form F-6 10 Section 5.7(a1.1(37) Form S-4 Governmental Approvals Section 5.7(a) GAAP Section 3.7(b1.1(38) Governmental Entity Section 3.6(b1.1(39) Governmental Official Group Section 3.5(e1.1(40) Hazardous Materials Guaranty Release Section 3.13(b2.10(b) HSR Act Indebtedness Section 3.6(b1.1(41) Indemnified Party(iesIndemnifiable Loss Section 1.1(42) Indemnifying Party Section 5.11(a6.4(a) IRS Indemnitee Section 3.11(a6.4(a) Liens Indemnity Payment Section 3.4 Material Adverse Effect 6.7(a) Information Section 8.9(c1.1(43) Merger Recitals Merger Consideration Information Statement Section 2.1(c)(i1.1(44) Merger Sub Insurance Proceeds Section 1.1(45) Insured Claims Section 1.1(46) Intellectual Property Section 1.1(47) Internal Control Audit and Management Assessments Section 7.2(a) Internal Reorganization Section 1.1(48) IP License Agreement Section 1.1 (49) IR Preamble New Financing Commitments IR Asset Transferee Section 5.13(a1.1(50) Non-U.S. Antitrust Laws IR Group Section 5.4(a)(i1.1(51) Non-U.S. Company Benefit Plan IR Indemnitees Section 3.11(a1.1(52) IR Ordinary Shares Section 1.1(53) IR Retained Assets Section 1.1(54) IR Retained Business Section 1.1(55) IR Retained Liabilities Section 1.1(56) Law Section 1.1(57) Liabilities Section 1.1(58) vi Defined Term Section Non-U.S. Parent Benefit Plan Liable Party Section 4.11(a2.9(b) LIBOR Section 1.1(59) Materials of Environmental Concern Section 1.1(60) Negotiation Period Section 8.1 New York Courts Section 10.18 NYSE Recitals OFAC Section 3.5(f1.1(61) Parent Other Party Section 2.9 Other Party’s Auditor Section 7.2(b) Party Preamble Parent ADS Recitals Parent Adverse Recommendation Change Person Section 5.16(d)(i1.1(62) Parent Alternative Proposal Policies Section 5.16(a1.1(63) Parent Benefit Plans Privilege Section 4.11(a7.7(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Privileged Information Section 4.1 Parent Material 7.7(a) Record Date Section 1.1(64) Record Holders Section 1.1(65) Records Section 1.1(66) Rules Section 8.2 Security Interest Section 1.1(67) Separation Expenses Section 10.5 Shared Contract Section 4.23(a2.3(a) Parent Options Specified Allegion Assets Section 4.3 Parent Permits 1.4(4)(iii) Specified Allegion Liabilities Section 4.5(b1.1(10)(iv) Parent Permitted Liens Subsidiary Section 4.21(a1.1(68) Parent Real Property Tax Section 4.5(d1.1(69) Parent Representatives Tax Contest Section 5.16(a1.1(70) Parent Reports Tax Matters Agreement Section 4.7(a1.1(71) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Tax Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f1.1(72) Third Party Provision Agreements Section 8.3 to the knowledge of 1.1(73) Third Party Claim Section 8.9(b6.4(b) UK FSMA Third Party Proceeds Section 2.2(b)(i6.7(a) UK Prospectus Rules Trademarks Section 5.7(d)(i1.1(47) UKLA Transfer Section 5.7(d)(i1.1(74) U.S. Company Benefit Plan Transition Services Agreement Section 3.11(a1.1(75) U.S. Parent Benefit Plan Voting Stock Section 4.11(a1.1(76) AGREEMENT SEPARATION AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).DISTRIBUTION AGREEMENT

Appears in 1 contract

Samples: Separation and Distribution Agreement (Allegion PLC)

Defined Term Section. Action Election Deadline Section 5.11(a1.9(b) ADS Depositary Election Form Section 4.3 Affected Employees Section 5.12(a1.9(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Election Form Record Date Section 1.2 Code Section 2.1(c)(iii)(A1.9(a) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a2.17(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i2.12(a) Exchange Act Section 3.4 2.5(b) Exchange Agent Section 2.2(a1.10(a) Exchange Fund Section 2.2(a1.10(a) Exchange Ratio Section 2.1(c)(i1.6(d) Excluded Shares Expenses Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a7.3(d) GAAP Section 3.7(b2.7(b) Governmental Entity good and defensible title Section 3.6(b2.14(e) Governmental Official governmental authority Section 3.5(e8.4(e) Hazardous Materials Substance Section 3.13(b2.17(a) HIPAA Section 2.12(e)(iv) HSR Act Section 3.6(b2.5(b) Hydrocarbons Section 2.14(b) Indemnified Party(iesParties Section 5.4(b) Intellectual Property Section 5.11(a) 2.20 IRS Section 3.11(a2.12(b) Liens Mailing Date Section 3.4 Material Adverse Effect Section 8.9(c1.9(a) Merger Recitals Merger Consideration Section 2.1(c)(i1.6(a) Merger Sub Preamble New Financing Commitments Mixed Consideration Election Shares Section 5.13(a1.9(b) Notice of Intended Change in the Company Recommendation Section 5.3(b) Non-U.S. Antitrust Laws Election Shares Section 5.4(a)(i1.9(b) Non-U.S. Company Benefit Plan Oil and Gas Properties Section 3.11(a2.14(b) vi Defined Term Option Section Non-U.S. 1.7(a) Outside Date Section 7.1(b)(i) Parent Preamble Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f3.12(a) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Board of Directors Section 5.16(d)(i3.4(d) Parent Alternative Proposal Common Stock Section 5.16(a3.3 Parent Employees Section 3.18 Parent Financial Advisor Section 3.4(d) Parent Benefit Plans Group Section 4.11(a3.12(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 3.1 Parent Material Contract Subsidiaries Section 4.23(a) 3.3 Parent Options Section 4.3 Parties Preamble Parent Permits Section 4.5(b3.6(c) Parent Permitted Liens Preferred Stock Section 4.21(a3.3 Parent Reserve Reports Section 3.14(c) Parent Real Property Rights Plan Section 4.5(d) 3.3 Parent Representatives Section 5.16(a) Schedule Article III Parent SEC Reports Section 4.7(a3.7(a) Parent Shareholder Approval Defined Term Section 4.20 Parent Superior Proposal PBGC Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i2.12(b) Per Share Cash Amount Consideration Section 2.1(c)(i1.6(d) Per Share Mixed Consideration Section 1.6(d) Per Share Stock Amount Consideration Section 2.1(c)(i1.6(d) Person person Section 3.5(e) PFIC Section 4.10(b8.4(f) Proxy Statement/Prospectus Section 5.7(a2.13 Real Property Leases Section 2.29 reasonable best efforts Section 8.4(g) Regulatory Filings Registration Statement Section 3.6(b) Required Jurisdiction 2.13 Restricted Shares Section 6.1(b)(iii1.7(b) Returns Section 3.10(a2.16(a) Rule 16b-3 Rights Section 5.9 2.3 Xxxxxxxx-Xxxxx Act Section 3.7(a2.8(a) SEC Section 3.7(a1.10(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”2.5(b), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).

Appears in 1 contract

Samples: Agreement and Plan of Merger (Mariner Energy Inc)

Defined Term Section. Action Allocation Section 5.11(a5.03(e) ADS Depositary Assignment and Assumption Agreement Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a2.09(a)(iii) Assumed Option Liabilities Section 2.1(c)(iii)(A2.04 Base Purchase Price Section 2.07(a) Assumed RSU Award Xxxx of Sale Section 2.1(c)(v)(B2.09(a)(i) Book Entry Share Buyer Preamble Buyer Guarantor Preamble Buyer Obligations Section 2.1(c)(i10.14(a) Business Day Buyer Released Matters Section 8.9(k5.14(a) Cash-Only Shares Buyer Released Parties Section 2.1(c)(i5.14(a) Certificate of Merger Buyer Releasing Parties Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares 7.02 (b) Buyer Specified Representations Section 4.3 6.03(b)(i) Buyer’s Statement Section 2.10(a) Cap Section 8.01(c) Claim Notice Section 8.03(a) Closing Section 1.2 2.08 Closing Date Section 1.2 Code 2.08 Closing Purchase Price Section 2.1(c)(iii)(A2.07(a) Company Preamble Company Acquisition Proposal Competing Transaction Section 5.2(a5.11(b)(i) Company Adverse Recommendation Change Condemnation Value Section 5.2(d)(i5.10(a)(ii) Company Benefit Plans Confidentiality Agreement Section 3.11(a5.04(a) Company Certificate Consent Section 2.1(c)(i3.03 Continuing Employees Section 5.07 Deductible Section 8.01(b)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Designated Account Section 5.12(d2.11(a) Company Material Adverse Effect Direct Costs Section 3.1 Company Material Contract Section 3.23(a5.15(b) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Easement Real Property Section 3.5(d3.11(a)(iii) Company Reports Easements Section 3.7(a3.11(a)(iii) Company Representatives Effect Definition of “Material Adverse Effect” Event of Loss Section 5.2(a5.10 Excluded Assets Section 2.03 Excluded Easements Section 3.11(c) Company Restricted Stock Awards Excluded Easements Deed Section 2.1(c)(iv2.09(a)(ii) Company Rights Facility Recitals Filing Section 2.5 Company Rights 3.03 Financial Assurances Section 2.03(l) Financial Statements Section 3.07(a) Forum Section 10.08(a) Gas Supply Agreement Section 2.5 Company RSU Awards 5.08(i) Indemnified Buyer Entities Section 2.1(c)(v8.01(a) Company Stockholder Approval Indemnified Entity Section 3.20 Company Stock Option 8.03(a) Indemnified Seller Entities Section 2.1(c)(iii)(A8.02(a) Company Superior Proposal Indemnifying Entity Section 5.2(d)(ii8.03(a) Independent Accountants Section 2.10(b) Index Section 2.11(d) Defined Term Section Competition Action Information Section 5.4(c10.13(b) Confidentiality Agreement Insurance Policies Section 5.2(a3.16 Interim Period Section 5.02(a) control KES Section 3.27 Cutoff 2.02(a) Major Loss Section 5.10(b) Material Contracts Section 3.10(a) MBM Materials Section 2.03(k) Monthly Earnout Statement Section 2.11(b) Objection Notice Section 2.11(b) Outside Date Section 8.9(e9.01(b) Definitive Financing Agreements Owned Real Property Section 5.13(b3.11(a)(i) Delaware Sub Party Preamble Deposit Agreement Permanent Pre-Arranged Shipper Section 4.3 Derivative Transaction Section 3.25(a5.22(b) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b3.09(b) Parent Permitted Liens Section 4.21(a3.11(a)(iv) Parent Pre-Arranged Capacity Release Section 5.22(b) Pre-Arranged Shipper Section 5.22(a) Privileged Information Section 10.13(c) Privileges Section 10.13(b) PUHCA Section 3.17 Purchase Price Section 2.07(a) QSE Receivable Section 2.02(a) Real Property Section 4.5(d3.11(a)(iii) Parent Representatives Real Property Deed Section 5.16(a2.09(a)(ii) Parent Reports Restoration Costs Section 4.7(a5.10(a)(i) Parent Shareholder Approval Retained Liabilities Section 4.20 Parent Superior Proposal 2.05 Schedule Update Section 5.16(d)(ii5.12 Seller Preamble Seller Guarantor Preamble Seller Intellectual Property Section 3.11(f) Parent UK Prospectus Seller Obligations Section 5.7(d)(i10.15(a) Per Share CashSeller Released Matters Section 7.02(b) Seller Released Parties Section 7.02(b) Seller Releasing Parties Section 5.14(a) Seller Specified Representations Section 6.01(b)(i) Short-Only Additional Cash Amount Term Pre-Arranged Capacity Release Section 2.1(c)(i5.22(a) Per Share Cash Amount Spread Strike Definition of “Spark Spread” Subsequent Transaction Section 2.1(c)(i5.08(b) Per Share Stock Amount Subsequent Transaction Plan Section 2.1(c)(i5.08(b) Person Taking Section 3.5(e) PFIC 5.10 Tax Contest Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f5.03(b) Third Party Provision Section 8.3 to the knowledge 8.03(a) Transition Services Section 5.15(a) Exhibit B Form of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN Xxxx of Sale XXXX OF MERGER THIS AGREEMENT AND PLAN SALE This XXXX OF MERGER SALE, dated as of [ ], 2017 (this “Agreement”) dated as Xxxx of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“ParentSale”), Pride Internationalis executed and delivered by Xxxxxx-Xxxxx Power Partners, Inc.L.P., a Delaware corporation limited partnership (the CompanySeller”), ENSCO Ventures LLCto La Frontera Holdings, LLC , a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware SubBuyer”).

Appears in 1 contract

Samples: Asset Purchase Agreement (Vistra Energy Corp)

Defined Term Section. Action Additional Issuer SEC Reports ​ Section 5.11(a2.7(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger ​ Aggregate Principal Amount ​ Section 1.1 Class A Ordinary Shares ​ Bankruptcy and Equity Exception ​ Section 2.3(a) ​ BCA ​ Recitals Class B Ordinary Shares ​ Change in Recommendation ​ Section 4.3 7.11(a) ​ Closing Section 1.2 1.4(a) ​ Closing Conditions ​ Article VI ​ Closing Date Section 1.2 Code 1.4(a) ​ Closing Notice ​ Section 2.1(c)(iii)(A1.4(b) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Schedule(s) ​ Article 3 III ​ Company ESPP Fundamental Representations ​ Section 5.12(d5.1(a) Company Material Adverse Effect Leased Real Property ​ Section 3.1 3.18(b) ​ Company Material Contract Owned Real Property ​ Section 3.23(a3.18(a) Company Permits Property ​ Section 3.5(b3.18(b) Company Permitted Liens ​ ​ ​ ​ Defined Term Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Lease ​ Section 3.5(d3.18(b) Company Related Party ​ Section 3.21 ​ Company Related Party Transactions ​ Section 3.21 ​ Contract Property ​ Section 3.18(e) ​ Conversant Investor ​ Recitals ​ Conversant Subscription Agreement ​ Recitals ​ Convertible Notes ​ Recitals ​ Current Credit Agreement ​ Section 7.8(f) ​ Damages ​ Section 9.2(a)(i) ​ Designated Court(s) ​ Section 9.16 ​ Disclosure Document ​ Section 7.5(a) ​ Disclosure Schedule(s) ​ Article III ​ Effectiveness Date ​ Section 7.3(a) ​ Election Notice ​ Section 7.7(c) ​ Filing Deadline ​ Section 7.3(a) ​ Final Offer Notice ​ Section 7.7(b) ​ Financial Statements ​ Section 3.4(a) ​ Indemnified Breaches ​ Section 9.2(a)(i) ​ Indemnifying Party ​ Section 9.2(a)(i) ​ Initial Offer Notice ​ Section 7.7(b) ​ Insurance Policies ​ Section 3.15 ​ Interim Financial Statements ​ Section 3.4(a) ​ Investor Indemnified Persons ​ Section 9.2(a)(i) ​ Investor Subscription Agreement ​ Recitals ​ Investor(s) ​ Preamble ​ Investor’s Closing Conditions ​ Article V ​ IPO Prospectus ​ Section 7.6(a) ​ Issuance Approval ​ Section 2.2(b) ​ Issuance Approval Meeting ​ Section 7.11(a) ​ Issuance Approval Meeting Deadline ​ Section 7.11(a) ​ Issuance Approval Proxy Statement ​ Section 7.11(a) ​ Issuer ​ Preamble ​ Issuer Board ​ Section 2.2(b) ​ Issuer Board Recommendation ​ Section 2.2(b) ​ Issuer Companies ​ Recitals ​ Issuer Disclosure Schedule(s) ​ Article II ​ Issuer Fundamental Representations ​ Section 5.1(a) ​ Issuer Indemnified Persons ​ Section 9.2(b) ​ Issuer Related Party ​ Section 2.9 ​ Issuer Related Party Transactions ​ Section 2.9 ​ Issuer SEC Reports ​ Section 2.7(a) ​ Issuer’s and Company’s Closing Conditions ​ Article VI ​ Latest Balance Sheet ​ Section 3.4(a) ​ Material Contracts ​ Section 3.7(a) Company Representatives ​ Material Permits ​ Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) 3.6 ​ ​ ​ ​ Exhibit B - 17 ​ Defined Term Section Competition Action Merger Closing ​ Recitals ​ Merger Closing Date ​ Section 5.4(c1.4(a) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub ​ Recitals ​ Merger Transaction ​ Recitals ​ Multiemployer Plan ​ Section 3.11(d) ​ New Securities Issuance ​ Section 7.7(a) ​ PIPE Investment ​ Recitals ​ Prospectus ​ Section 9.2(a)(ii) ​ Purchase Price ​ Section 1.3 ​ Registrable Securities ​ Section 7.3(a) ​ Registration Period ​ Section 7.3(d)(i) ​ Resale Registration Statement ​ Section 7.3(a) ​ SEC SPAC Accounting Changes ​ Section 2.13(d) ​ Sponsor ​ Preamble New Financing Commitments ​ Subscription Agreements ​ Recitals ​ Suspension Event ​ Section 5.13(a7.3(e) Non-U.S. Antitrust ​ Transaction ​ Recitals ​ Transaction Documents ​ Recitals ​ Trust Agreement ​ Section 2.8 ​ Trustee ​ Section 2.8 ​ Underlying Shares ​ Section 1.6 ​ Union ​ Section 3.14(g) ​ Year End Financial Statements ​ Section 3.4(a) ​ ​ ​ ​ EXHIBIT C Form of Convertible Note ​ AGREED FORM ​ THE SALE OF THIS SECURITY (INCLUDING ANY SECURITIES ISSUABLE UPON CONVERSION) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT, AS AMENDED OR APPLICABLE STATE SECURITIES LAWS. THIS SECURITY (INCLUDING ANY SECURITIES ISSUABLE UPON CONVERSION) HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO ITS DISTRIBUTION OR RESALE, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SALE OF THIS SECURITY (INCLUDING ANY SECURITIES ISSUABLE UPON CONVERSION) UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, OR AN EXEMPTION THEREFROM. ​ THIS NOTE HAS BEEN ISSUED WITH “ORIGINAL ISSUE DISCOUNT” (WITHIN THE MEANING OF SECTION 1272 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED). UPON WRITTEN REQUEST (ADDRESSED TO [●] AT UNITED HOMES GROUP, INC., 00 X XXXXX XXXXX XXXXX, XXXX, XXXXX XXXXXXXX 00000), THE ISSUER WILL PROMPTLY MAKE AVAILABLE TO ANY HOLDER OF THIS NOTE THE FOLLOWING INFORMATION: (1) THE ISSUE PRICE AND ISSUE DATE OF THE NOTE; (2) THE AMOUNT OF ORIGINAL ISSUE DISCOUNT ON THE NOTE; AND (3) THE YIELD TO MATURITY OF THE NOTE. ​ UNITED HOMES GROUP, INC. ​ SENIOR CONVERTIBLE PROMISSORY NOTE ​ ​ $[●] [●], 2023 ​ FOR VALUE RECEIVED, United Homes Group, Inc., (formerly known as DiamondHead Holdings Corp.) a corporation organized under the Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 of the state of Delaware (the “Issuer”), HEREBY promises to pay to the knowledge order of Section 8.9(b[Holder], or its registered assigns (the “Holder”), the principal sum of [●] U.S. dollars ($[●]) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this the AgreementPrincipal Amount”) plus the aggregate amount of accrued interest on the outstanding Principal Amount, in each case pursuant to the terms and conditions of that certain convertible note purchase agreement, dated as of February 6March 21, 20112023, is by and among Ensco plcthe Issuer, a public limited company organized under the laws of England and Wales (“Parent”)Great Southern Homes, Pride International, Inc., a Delaware corporation Inc. (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company the Holder and an indirect, wholly owned subsidiary of Parent the other investors named therein (the Merger SubNote Purchase Agreement”), . Interest shall commence accruing as of the date hereof (the “Issue Date”) and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary shall continue to accrue on the outstanding principal of Parent this senior convertible promissory note (this Delaware SubNote).) as set forth in Article 1 until fully paid or extinguished in accordance with the provisions hereof. ​

Appears in 1 contract

Samples: Subscription Agreement (United Homes Group, Inc.)

Defined Term Section. Action Backstop Parties Preamble Backstop Party Preamble Backstop Party Replacement Section 5.11(a2.3(a) ADS Depositary Backstop Party Replacement Period Section 4.3 Affected Employees Section 5.12(a2.3(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Bankruptcy Code Recitals Class B Ordinary Shares Section 4.3 Bankruptcy Court Recitals Chapter 11 Case Recitals Closing Section 1.2 2.5(a) Closing Date Section 1.2 Code 2.5(a) Commitment Agreement Preamble Common Stock Section 2.1(c)(iii)(A7.1(cc) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Debtor Recitals Economic Change Section 5.2(d)(i8.05 of the PSA Employee Representatives Section 4.14(a) Company Environmental Laws Section 4.19(a) Escrow Release Section 2.4(b) Exide Preamble Existing European Facilities PSA Term Sheet Expense Reimbursement Section 3.3 Fee Notes Section 3.1 Fee Shares Sect Section 3.1 Financial Reports Section 6.6(a) Financial Statements Section 4.9 Foreign Benefit Plans Section 3.11(a4.21(h) Company Certificate Funding Notice Section 2.1(c)(i2.4(a) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP GAAP Section 5.12(d4.9 Indemnified Claim Section 8.2 Indemnified Person Section 8.1 Indemnifying Party Section 8.1 Infringed Section 4.15 Initial Funding Notice Section 2.4(a) Company Material Adverse Effect Legal Proceedings Section 3.1 Company 4.13 Legend Section 6.14 Losses Section 8.1 Material Contract Section 3.23(a4.24 Money Laundering Laws Section 4.26 Multiemployer Plan Section 4.21(b) Company Permits Non-Waiving Backstop Parties Section 3.5(b7.3 Outside Date Section 9.1(g) Company Permitted Liens Party Preamble Petition Date Recitals Plan Recitals Pre-Closing Period Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) 6.3 PSA Recitals PSA Term Sheet Recitals Defined Term Section Competition Action Regulation S Section 5.4(c5.8 Related Purchaser Section 2.6(a) Confidentiality Agreement Replacing Backstop Parties Section 5.2(a2.3(a) control Restructuring Transactions Recitals Rights Offering Commitment Section 3.27 Cutoff Date 2.1 Sale Section 8.9(e4.02(c) Definitive Financing Agreements of the PSA Subsequent Funding Notice Section 5.13(b2.4(a) Delaware Sub Preamble Deposit Agreement Ultimate Purchaser Section 4.3 Derivative Transaction 2.6(b) Waiving Backstop Parties Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange 7.3 WARN Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).4.14

Appears in 1 contract

Samples: Backstop Commitment Agreement (Exide Technologies)

Defined Term Section. Action Section 5.11(a280G Approval 5.5(e) ADS Depositary Section 4.3 Affected Employees Section 5.12(aAccounting Referee 2.3(d) Affiliate Section 3.27 Acquisition Proposal 5.5(c) Aggregate Equity Release Amount 5.11(b) Aggregate Option Payment 2.2(a) Agreement Preamble Antitrust Laws Section 5.4(cAgreement Date Preamble Articles of Merger 2.5 Basket 9.4(d) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(kCash Consideration 2.1(d) Cash-Only Shares Section 2.1(c)(iin-Lieu 2.1(d) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Certificates 2.7(b) Charter Documents 3.1 Claim 9.5(a) Closing Section 1.2 Balance Sheet 2.3(c) Closing Date Section 1.2 Code Section 2.1(c)(iii)(APay-Off Debt 5.12 Closing Working Capital Statement 2.3(c) Company Preamble Company Acquisition Proposal Section 5.2(aBenefit Arrangement 3.16(h) Company Adverse Recommendation Change Section 5.2(d)(iContinuing Employee 6.5(a) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Letter Article 3 Company ESPP Section 5.12(dIndemnification Provisions 6.4(a) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(aIndemnified Parties 6.4(a) Company Permits Section 3.5(b) Indemnifying Parties 9.2 Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(aRepresentation Indemnities 9.2(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(c5.8(a) Confidentiality Agreement Section 5.2(a5.9 Contested Claim 9.8(a)(ii) control Section 3.27 Cutoff Date Section 8.9(eDamages 9.2 Data Room Article 3 Disputed Item 2.3(d) Definitive Financing Agreements Section 5.13(bDisregarded Shares 2.1(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a2.5 Employee Covenants Agreement Recitals Equity Release Agreement 5.11(b) ERISA Section 3.11(aEscrow Agreement 2.4(b) ERISA Affiliate Section 3.11(cEscrow Cash 2.4(a) Equity Compensation Exchange Ratio Section 2.1(c)(iEscrow Fund 2.4(b) Escrow Shares 2.4(a) Estimated Adjusted Transaction Value 2.3(b) Estimated Closing Balance Sheet 2.3(a) Estimated Closing Working Capital Amount 2.3(a) Exchange Act Section 3.4 Exchange Agent Section 2.2(a2.7(a) Exchange Fund Section 2.2(aAgreement 2.7(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(bExport Approvals 3.23(a) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(bAdjusted Transaction Value 2.3(f)(iv) Governmental Entity Section 3.6(bPermits 3.15(b) Governmental Official Section 3.5(eInformation Statement 5.5(b) Hazardous Materials Section 3.13(bInsurance Coverage 5.19 Invention Assignment Agreement 3.14(k) HSR Act Section 3.6(bLicensed IP 3.14(c) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Major Stockholders Recitals Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(aNotice of Claim 9.5(b) Non-U.S. Antitrust Laws Section 5.4(a)(iObjection 2.3(d) Non-U.S. Objection Period 2.3(d) Offer Letter Recitals Option Payment 2.2(a) Option Surrender Agreement 7.2(x) Owned Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(fIP 3.14(c) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(iBenefit Plans 6.5(b) Parent Alternative Proposal Section 5.16(a) Indemnified Persons 9.2 Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Indemnifying Parties 9.3 Parent Reports Section 4.7(a4.8 Parent Representation Indemnities 9.3(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(iiPre-Closing Tax Claim 10.3(c) Parent UK Prospectus Section 5.7(d)(iPrivacy Notices 3.14(s) Privacy Policy 3.14(s) Qualifying Holder Stock Consideration 2.1(d) Representative Preamble Representative Expenses 9.13(b) Response Date 2.3(d) Securityholder Indemnified Persons 9.3 Series A Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Series B-1 Per Share Cash Amount Section 2.1(c)(i2.1(c)(ii) Series C Per Share Stock Amount Section 2.1(c)(i2.1(c)(iii) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(bSeries D Per Share Amount 2.1(c)(iv) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(dCustomer 3.20(b) Significant Supplier 3.20(c) Specified Person 3.4(e) Stockholder Approval 3.3(e) Stockholder Consent Recitals Stockholder Letter of Transmittal 2.7(b) Straddle Tax Claim 10.3(b) Support Agreements Recitals Surviving Entity Section 1.1 tax(esCorporation Recitals Takeover Statute 3.3(f) Section 3.10(fTax Claim 10.3(a) Third Third-Party Provision Section 8.3 to the knowledge of Section 8.9(bClaim 9.5(b)(ii) UK FSMA Section 2.2(b)(iTransfer Taxes 10.4 Treasury Shares 2.1(b) UK Prospectus Rules Section 5.7(d)(iValue 9.8(c) UKLA Section 5.7(d)(iWaived 280G Benefits 5.5(e) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”WBCA Recitals Withholding Options 2.7(a), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).

Appears in 1 contract

Samples: Agreement and Plan of Merger (Vonage Holdings Corp)

Defined Term Section. Action Section 5.11(a280G Payments ‎5.10 Acquisition Proposal ‎5.1(b) ADS Depositary Section 4.3 Affected Employees Section 5.12(aActual Cash ‎1.11(c)(i) Actual Closing Indebtedness ‎1.11(c)(i) Actual Net Working Capital Adjustment Amount ‎1.11(c)(i) Actual Transaction Expenses ‎1.11(c)(i) Adjustment Escrow Amount ‎1.10(b)(iii) Affiliate Section 3.27 Transaction ‎2.22 Agreement Preamble Antitrust Anti-corruption Laws Section 5.4(c‎2.9(c)(iii) Alternate Transaction ‎5.1(a) Applicable Laws Section 3.5(aData Protection Requirements ‎2.8(a)(ii) Assumed Option Section 2.1(c)(iii)(ABonus Payment Acknowledgment ‎5.12(a) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(iCash ‎1.11(b)(ii) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 ‎1.2 Certificates ‎1.10(c) Closing Section 1.2 ‎1.2 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A‎1.2 Closing Statement ‎1.11(c)(i) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(iBalance Sheet ‎2.5(a) Company Benefit Plans Section 3.11(aPlan ‎2.12(a) Company Certificate Section 2.1(c)(iBoard Recitals Company Charter Documents ‎2.1(b) Company Common Stock Recitals Disclosure Letter ‎Article II Company Disclosure Schedule Article 3 Company ESPP Section 5.12(dEngagements ‎9.11(b) Company Material Adverse Effect Section 3.1 Indemnified Liabilities ‎5.6(a) Company Material Contract Section 3.23(aIndemnified Parties ‎5.6(a) Company Indemnified Proceedings ‎5.6(a) Company Intellectual Property Rights ‎2.8(a)(i) Company IT Systems ‎2.8(p) Company-Owned Intellectual Property Rights ‎2.8(a)(ii) Company-Owned Software ‎2.8(j) Company Permits Section 3.5(b‎2.9(b) Company Permitted Liens Section 3.21(aProducts ‎2.8(a)(v) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(dReleased Parties ‎9.13(a) Company Reports Section 3.7(aRegistered Intellectual Property Rights ‎2.8(a)(iv) Company Representatives Section 5.2(aSoftware ‎2.8(m) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Defined Term Section Competition Action Section 5.4(cSubsidiary Charter Documents ‎2.1(c) Confidentiality Agreement Section 5.2(aAgreements ‎5.2(a) control Section 3.27 Cutoff Date Section 8.9(eConsideration Spreadsheet ‎5.14 Continuing Employee ‎5.5 Copyrights ‎2.8(a)(v) Definitive Financing Agreements Section 5.13(bCovered Employee ‎4.1(b)(xviii) Data Breach ‎2.8(r) Data Partners ‎2.8(r) Deductible Amount ‎7.3(c)(i) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(aLaw Recitals Dispute Notice ‎1.11(c)(ii) DGCL Recitals Disregarded Shares ‎1.7(a) Dissenting Shares Section 2.1(c)(vii‎1.7(e)(i) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 ‎1.2 Employee ‎2.12(a) Employment Agreement Recitals End Date ‎8.1(b) Environmental Laws Section 3.13(aLaw ‎2.15(b) Environmental Permit ‎2.15(b) ERISA Section 3.11(a‎2.12(a) ERISA Affiliate Section 3.11(cEscrow Agreement ‎1.10(b)(iii) Equity Compensation Exchange Ratio Section 2.1(c)(iEscrow Accounts ‎1.10(b)(iii) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Escrow Period ‎7.7 Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b‎1.10(b)(ii) Final Parent Stock Price Section 2.1(c)(iAccounting Firm ‎1.11(c)(ii) Financing Section 5.13(aFinal Cash ‎1.11(c)(vi) Financing Commitments Section 5.13(aFinal Closing Indebtedness ‎1.11(c)(vi) Financing Sources Section 5.13(aFinal Net Working Capital Adjustment Amount 1.11(c)(vi) Form F-6 Section 5.7(aFinal Total Consideration 1.11(c)(vi) Form S-4 Section 5.7(aFinal Transaction Expenses 1.11(c)(vi) Financial Statements ‎2.6(a) Foreign Benefit Plan ‎2.12(g) Fundamental Representations ‎7.1 Fundamental Termination Date ‎7.1 GAAP Section 3.7(b‎2.5(a) Governmental Entity Section 3.6(bGovernment Person ‎2.9(c)(iii) Governmental Official Section 3.5(eGuaranteed Obligations ‎5.15(a) Hazardous Materials Section 3.13(bGuarantor Preamble In-the-Money Series B Warrant ‎1.8(b) HSR Act Section 3.6(bIn-the-Money Series B-1 Warrant ‎1.8(a) In-the-Money Vested Option ‎1.9(a) In-the-Money Warrants ‎1.8(b) Increased Premium Amount ‎5.6(c) Indemnification Tax Benefit ‎7.3(f) Indemnified Party(iesParties ‎7.3(a) Section 5.11(aIndemnity Escrow Account ‎1.10(b)(iii) Indemnity Escrow Amount ‎1.10(b)(iii) Information Statement ‎5.8 Intellectual Property Rights ‎2.8(a)(vii) Invoice ‎5.12(d) IP Assignment Agreement ‎2.8(a)(i) IRS Section 3.11(a‎2.12(b)(ii) Liens Section 3.4 Material Adverse Effect Section 8.9(cLetter of Transmittal ‎1.10(c) Malicious Code ‎2.8(m) Materials of Environmental Concern ‎2.15(b) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(aNecessary Consents ‎2.4(b) NonNet Working Capital ‎1.11(b)(i) Officer’s Certificate ‎7.4(a) OMM ‎9.11(a) Open Source Software ‎2.8(a)(viii) Out-U.S. Antitrust Laws Section 5.4(a)(iof-the-Money Series B-1 Warrant ‎1.8(a) NonOut-U.S. Company Benefit Plan Section 3.11(aof-the-Money Series B Warrant ‎1.8(b) vi Defined Term Section NonOut-U.S. Parent Benefit Plan Section 4.11(aof-the-Money Warrants ‎1.8(b) NYSE Recitals OFAC Section 3.5(f) Parachute Payment Waiver ‎5.9 Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 ‎3.1 Parent Material Contract Section 4.23(aReleased Parties ‎9.13(b) Parent Options Section 4.3 Parent Patent Family ‎2.8(a)(ix) Patents ‎2.8(a)(v) Paying Agent ‎1.10 Payoff Letter ‎5.12(d) Permits Section 4.5(b‎2.9(b) Parent Permitted Liens Section 4.21(aPersonal Information ‎2.8(a)(x) Parent Real Policy Only Outside Date ‎7.3(c)(iv) Preliminary Cash ‎1.11(a) Preliminary Closing Indebtedness ‎1.11(a) Preliminary Closing Statement ‎1.11(a) Preliminary Net Working Capital Adjustment Amount ‎1.11(a) Preliminary Total Consideration ‎1.11(a) Preliminary Transaction Expenses ‎1.11(a) Privacy Requirements ‎2.8(r) Recoverable Claim ‎7.3(c)(iv) Recoverable Claim Excess ‎7.3(c)(iv) Registered Intellectual Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(aRights ‎2.8(a)(xi) Regulatory Filings Section 3.6(bFees ‎5.4(a) Required Jurisdiction Section 6.1(b)(iiiRepresentative ‎7.8(a) Returns Section 3.10(aRepresentative Expenses ‎7.8(b) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(aRequisite Vote ‎2.3 Restricted Cash ‎1.11(b)(ii) SEC Section 3.7(aSME ‎2.7(a)(xxii) Securities Act Section 3.6(bSoftware ‎2.8(a)(xii) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(dStandard Software ‎2.8(a)(xiii) Subrogation Provision ‎5.13 Surviving Entity Section 1.1 tax(esCorporation ‎1.1 Tail Policy ‎5.6(c) Section 3.10(fTax Claim ‎5.11(b) Technology ‎2.8(a)(xiv) Third Party Provision Section 8.3 to the knowledge of Section 8.9(bClaim ‎7.9(a) UK FSMA Section 2.2(b)(iTotal Consideration ‎1.6 Trade Secrets ‎2.8(a)(v) UK Prospectus Rules Section 5.7(d)(iTrademarks ‎2.8(a)(v) UKLA Section 5.7(d)(iTransfer Taxes ‎5.11(g) U.S. Company Benefit Plan Section 3.11(aUnresolved Claim ‎7.7 Unvested Option ‎1.9(b) U.S. Parent Benefit Plan Section 4.11(aVested Option ‎1.9(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).*****

Appears in 1 contract

Samples: Agreement and Plan of Merger (Allegro Microsystems, Inc.)

Defined Term Section. Action Amalco Section 5.11(a1.1(a) ADS Depositary Arrangement Section 4.3 Affected Employees 1.3(a)(i) Arrangement Resolution Recitals Articles of Arrangement Section 5.12(a1.3(f) Affiliate Bankruptcy and Equity Exception Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) 2.4 Business Day Section 8.9(k7.11 Canadian Proceedings Section 2.24 CBCA Section 1.3(a) Cash-Only Shares Change in Recommendation Section 2.1(c)(i4.8(a) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 1.9(a) Closing Date Section 1.2 1.9(a) Code Section 2.1(c)(iii)(A2.7(h) commercially reasonable efforts Section 7.11 Company Preamble Company Acquisition Proposal Arrangement Amount Section 5.2(a7.11 Company Circular Section 7.11 Company Common Shares Recitals Company Contract Section 7.11 Company Debt Instruments Section 1.3(b) Company Adverse Recommendation Change Deferred Share Units Section 5.2(d)(i) 7.11 Company Disclosure Schedule ARTICLE II Company DSU Plan Section 1.2 Company Employee Benefit Plans Section 3.11(a2.13(a) Company Certificate ERISA Affiliate Section 2.1(c)(i2.13(a) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Financial Statements Section 5.12(d2.6(a) Company Indenture Section 7.11 Company Initial Shares Section 7.11 Company Intellectual Property Section 2.15(a) Company Labor Contracts Section 2.14(a) Company Meeting Section 1.3(b) Defined Term Section Company Non-US Benefit Plan Section 2.13(l) Company’s Ordinary Course of Business Section 7.11 Company Outstanding Amount Section 7.11 Company Permits Section 2.10 Company Preferred Shares Section 1.3(b) Company Preferred Shares Redemption Section 1.3(c) Company Preferred Shares Redemption Date Section 1.3(c) Company Recent Balance Sheet Section 2.6(a) Company Requisite Shareholder Vote Section 2.4 Company Restricted Share Units Section 7.11 Company Rights Agreement Section 2.23 Company RSU Plan Section 1.2 Company’s Costs Section 6.2(f) Company Securities Reports Section 2.22(b) Company Warrant Cancellation Section 7.11 Company Warrants Section 7.11 Confidentiality Agreement Section 4.18 Consent Agreement Section 4.3(d) Contract Section 7.11 Court Recitals Debt Commitment Letter Section 3.22 Debt Financing Section 4.4(a) Director Section 1.3(f) Dissent Rights Section 7.11 Effective Price Section 7.11 Effective Time Section 7.11 Employee Benefit Plans Section 7.11 Environmental Laws Section 2.12(a) Equity Interests Section 7.11 Equity Payment Amounts Section 7.11 vi Defined Term Section ERISA Section 7.11 ERISA Affiliate Section 7.11 Escrowed Shares Section 7.11 Exchange Act Section 1.4(b) Final Order Section 7.11 Financing Parties Section 4.4(b) Form S-4 Section 7.11 General Developments Section 7.11 Governmental Entity Section 7.11 Hazardous Substance Section 7.11 HSR Act Section 2.2 Indemnified Parties Section 4.11(a) Intellectual Property Rights Section 7.11 Interim Order Section 7.11 Law Section 7.11 Liens Section 7.11 Material Adverse Effect Section 3.1 Company Material Contract 7.11 Multiemployer Plan Section 3.23(a) Company Permits 7.11 Order Section 3.5(b) Company 7.11 Party or Parties Section 7.11 Person Section 7.11 Permitted Liens Section 3.21(a) Company Preferred Stock 7.11 Plan of Arrangement Recitals Plan of Reorganization Section 3.3 Company Real Property 7.11 Regulatory Law Section 3.5(d) Company Reports 7.11 Related Party Contracts Section 3.7(a) Company 7.11 Representatives Section 5.2(a4.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Revolving Credit Agreement Section 2.5 Company RSU Awards 1.3(b) SEC Section 2.1(c)(v1.3(b) Company Stockholder Approval SEC Clearance Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii1.3(b) Defined Term Section Competition Action Securities Authorities Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental 7.11 Securities Laws Section 3.13(a7.11 Senior Notes Indenture Section 1.3(b) ERISA Share Encumbrances Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation 7.11 Share Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) vi Defined Term Section Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b1.1(b) Significant Subsidiary Section 3.4 Subsidiary 7.11 Subsidiaries Section 8.9(d7.11 Superior Proposal Section 7.11 Taxes Section 7.11 Tax Return Section 7.11 Term Facility Agreement Section 1.3(b) Surviving Entity Termination Date Section 1.1 tax(es6.1(c) Total Shares Outstanding Section 3.10(f7.11 Transaction Developments Section 7.11 U.S. Bankruptcy Code Section 7.11 U.S. Bankruptcy Court Section 7.11 U.S. Proceedings Section 2.24 U.S. Securities Act Section 2.22(a) Third Party Provision Voting and Support Agreement Recitals Voting Debt Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) 7.11 ARRANGEMENT AGREEMENT AND PLAN OF MERGER THIS ARRANGEMENT AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated is made and effective as of February 6January 25, 20112010 between Quad/Graphics, is by and among Ensco plcInc., a public limited company corporation organized and existing under the laws of England and Wales the State of Wisconsin, U.S.A. (“ParentAcquiror”), Pride International, and World Color Press Inc., a Delaware corporation organized and existing under the laws of Canada (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”). Capitalized terms used but not otherwise defined in this Agreement shall have the meaning set forth in Section 7.11.

Appears in 1 contract

Samples: Arrangement Agreement (World Color Press Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.